学术周报 · IF≥10

眼科领域文献阅读汇编

2026年第41周 (2026-10-08) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选≥10 · 完整摘要不截断
收录论文
36
临床研究
14
基础研究
22
IF≥20
6
IF 10-20
30
子领域
9
期刊种类
25
数据日期
2026-10-08

★本周 Top 10 高影响力文献

#论文期刊IF
1Two-terminal photoelectric synapses for attojoule neuromorphic vision.Chemical Society reviewsIF 48.3
2Decoding systemic vascular health and hypertensive disorders in pregnancy through retinal imaging an...Nature biotechnologyIF 44.5
3An aberration-corrected bionic eye for full-colour vision and event-driven motion detection.Nature materialsIF 38.0
4A dual-pronged strategy for bacterial keratitis: ROS-responsive hydrogel eye drops enabling potent d...Bioactive materialsIF 23.6
5CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Bre...Cancer researchIF 22.6
6Noninvasive optical coherence tomography biomarker for Alport syndrome, COL4-related focal segmental...Kidney internationalIF 21.8
7Adaptive zones of feliforms and evolutionary regimes within terrestrial mammalian carnivores.Nature ecology & evolutionIF 17.1
8Cellular and molecular mechanisms of nasolacrimal duct obstruction: New insights into CD4+ T cell-MI...Journal of advanced researchIF 17.1
9Revolutionizing vision using corneal 3D printing.Trends in biotechnologyIF 16.6
10Adaptive and degenerative mitochondrial remodeling define distinct redox states in age-related macul...Redox biologyIF 16.2

Ŧ期刊分布统计

期刊篇数IF
Ophthalmology7IF 10.9
Ageing research reviews3IF 15.5
Science advances2IF 13.9
Acta biomaterialia2IF 10.4
EClinicalMedicine2IF 12.8
Nature biotechnology1IF 44.5
Molecular biomedicine1IF 13.0
Chemical Society reviews1IF 48.3
Cancer research1IF 22.6
JAMA network open1IF 11.7

1视网膜疾病 (13篇)

临床研究 (4篇)

JAMA network open IF 11.7 2026-10-01 PMID: 42826018
The risk of diabetic microvascular complications is well established among smokers with type 2 diabetes. However, whether and to what extent this excess risk declines according to smoking cessation duration remains unclear. To investigate the association between smoking cessation duration and the risk of incident diabetic microvascular complications in patients with diabetes. This nationwide, population-based cohort study included participants first diagnosed with type 2 diabetes in Korea between 2003 and 2013 and whose smoking status was assessed at least 4 times across repeated health checkups, with a final checkup during 2009 to 2013. Data were analyzed from November 10, 2025, to April 16, 2026. Smoking status and cessation duration. Quitters were defined as participants who reported current smoking at their initial health checkup and reported smoking cessation at all subsequent checkups without relapse. Continuous smokers were defined as participants who consistently reported current smoking at every health checkup. Among quitters, smoking cessation duration was categorized as less than 2, 2 to 3, 4 to 5, 6 to 7, and 8 or more years. Outcomes of interest were incident diabetic microvascular complications, including diabetic nephropathy, retinopathy, and neuropathy, identified using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) diagnostic codes. Cox proportional hazards models were used to estimate unadjusted and adjusted hazard ratios (aHRs) and 95% CIs. A total of 209 698 adults (mean [SD] age, 57.2 [10.3] years; 127 823 [61.0%] female) were included in the analyses. Compared with continuous smokers, cessation for 8 or more years was associated with a lower risk of all microvascular complications (aHR, 0.81; 95% CI, 0.70-0.95), diabetic nephropathy (aHR, 0.79; 95% CI, 0.64-0.94), diabetic retinopathy (aHR, 0.59; 95% CI, 0.36-0.97), and diabetic neuropathy (aHR, 0.80; 95% CI, 0.66-0.98). Smoking cessation for 6 to 7 years was associated with lower risk of diabetic neuropathy (aHR, 0.76; 95% CI, 0.64-0.89). In subgroup analyses by sex, these associations were significant only among male participants (eg, all microvascular complications: aHR, 0.82; 95% CI, 0.70-0.95). In this retrospective cohort study of patients with diabetes, smoking cessation for 8 or more years was associated with a lower risk of all diabetic microvascular complications, diabetic nephropathy, retinopathy, and neuropathy compared with continuous smoking. These associations were observed mainly among male participants, underscoring the potential importance of sustained long-term smoking cessation for microvascular risk reduction.
中文摘要:2型糖尿病吸烟者中糖尿病微血管并发症风险已明确。然而,这种超额风险是否以及随戒烟持续时间延长而下降仍不清楚。旨在探讨糖尿病患者戒烟持续时间与新发糖尿病微血管并发症风险之间的关联。这项全国性、基于人群的队列研究纳入2003年至2013年在韩国首次诊断为2型糖尿病的参与者,且在反复健康检查中至少4次评估吸烟状况,末次检查在2009年至2013年。数据分析时间为2025年11月10日至2026年4月16日。暴露为吸烟状况和戒烟持续时间。戒烟者定义为在初次健康检查时报告当前吸烟、并在随后所有检查中报告戒烟且未复吸的参与者。持续吸烟者定义为在每次健康检查中均报告当前吸烟的参与者。在戒烟者中,戒烟持续时间分为少于2年、2至3年、4至5年、6至7年和8年及以上。关注结局为新发糖尿病微血管并发症,包括糖尿病肾病、视网膜病变和神经病变,通过国际疾病分类第十次修订本(ICD-10)诊断代码识别。采用Cox比例风险模型估计未调整和调整后的风险比(aHRs)及95%CI。共209698名成人(平均[SD]年龄57.2[10.3]岁;127823名[61.0%]女性)纳入分析。与持续吸烟者相比,戒烟8年及以上与所有微血管并发症风险降低相关(aHR,0.81;95%CI,0.70-0.95)、糖尿病肾病(aHR,0.79;95%CI,0.64-0.94)、糖尿病视网膜病变(aHR,0.59;95%CI,0.36-0.97)和糖尿病神经病变(aHR,0.80;95%CI,0.66-0.98)。戒烟6至7年与糖尿病神经病变风险降低相关(aHR,0.76;95%CI,0.64-0.89)。按性别亚组分析中,这些关联仅在男性参与者中显著(例如,所有微血管并发症:aHR,0.82;95%CI,0.70-0.95)。在这项糖尿病患者回顾性队列研究中,与持续吸烟相比,戒烟8年及以上与所有糖尿病微血管并发症、糖尿病肾病、视网膜病变和神经病变风险降低相关。这些关联主要在男性参与者中观察到,强调长期持续戒烟对降低微血管风险可能具有重要意义。
EClinicalMedicine IF 12.8 2026-10 PMID: 42774824
Self-stigma is a barrier to treatment-seeking among survivors of childhood maltreatment. Although brief online interventions have effectively reduced stigma toward mental disorders, few have targeted self-stigma among childhood maltreatment survivors, with none being tested across multiple countries. Here we examined whether a brief, social contact-based video could reduce self-stigma and increase help-seeking intentions across six countries. In this completed, international, multicentre, single-blind, randomised controlled trial (ClinicalTrials.gov: NCT06159075) with 1:1 allocation and concealed assignment, young adults with a history of childhood maltreatment from the USA, Sweden, Switzerland, Japan, South Africa, and Türkiye were randomly assigned to either a social-contact video intervention (featuring a survivor's personal story acknowledging shame and modelling recovery) or a length-matched psychoeducation control. Participant blinding was not feasible; participants were unaware of the alternative condition, and investigators and analysts were blinded throughout. Prespecified primary outcomes were self-stigma (comprising of Alienation, Stereotype Endorsement, Secrecy, Perceived Recovery) and help-seeking intentions, assessed before and after intervention and at 30-day follow-up; following peer review, Perceived Recovery was designated the focal outcome for hypothesis testing, with the remaining domains analysed as secondary outcomes. Between-group differences at each timepoint were estimated using linear mixed-effects models adjusting for baseline scores. Adverse events were not assessed; no harms were reported. Enrolment began on April 1st, 2024, and was completed on August 29, 2025. The intention-to-treat analysis included 2499 participants (mean age 27.1 years, SD 5.1; 1488 (61.9%) female). The social contact intervention produced a small but statistically significant improvement in Perceived Recovery relative to the psychoeducational control after intervention (adjusted mean difference [AMD] 0.201, 95% CI 0.076-0.327; p = 0.0020). No significant between-group differences emerged for Alienation, Stereotype Endorsement, Secrecy, or Help-Seeking Intentions, and all remained non-significant after Benjamini-Hochberg false discovery rate correction. Among US participants-the only site with sufficient follow-up data-no significant between-group difference was observed in Perceived Recovery at 30-day follow-up (AMD 0.050, 95% CI -0.306 to 0.407; p = 0.78), indicating that a single brief exposure was insufficient to produce durable change. A single social contact-based video did not reduce most self-stigma domains or improve help-seeking relative to a psychoeducational control. More intensive or targeted approaches are needed to meaningfully address self-stigma among childhood maltreatment survivors. SHN received support from the Azrieli Foundation Early Career Faculty Fellowship. Data collection in the USA was funded from discretionary research funds at NYSPI. Regarding data collection in Japan, this work was supported by JSPS, KAKENHI Grant Number JP 23K02998. In South Africa, the study was supported by the South African Medical Research Council Unit on the Genomics of Brain Disorders. Data collection costs in other countries were covered by the participating institutions/researchers.
中文摘要:自我污名是童年虐待幸存者寻求治疗的障碍。尽管简短在线干预可有效减少对精神障碍的污名,但少有干预针对童年虐待幸存者的自我污名,且无一在多个国家进行测试。在此,我们检验了一段简短的、基于社会接触的视频是否能在六个国家减少自我污名并提高求助意向。在这项已完成的国际、多中心、单盲、随机对照试验中(ClinicalTrials.gov:NCT06159075),按1:1分配并采用隐蔽分组,来自美国、瑞典、瑞士、日本、南非和土耳其的有童年虐待史的年轻成人被随机分配到社会接触视频干预组(呈现一位幸存者承认羞耻并示范康复的个人故事)或长度匹配的心理教育对照组。参与者盲法不可行;参与者不知道另一条件,研究者和分析人员全程设盲。预设主要结局为自我污名(包括疏离感、刻板印象认同、保密、感知康复)和求助意向,在干预前、干预后及30天随访时评估;经同行评审后,感知康复被指定为假设检验的焦点结局,其余维度作为次要结局分析。各时间点组间差异采用线性混合效应模型并调整基线评分进行估计。未评估不良事件;未报告伤害。入组于2024年4月1日开始,于2025年8月29日完成。意向性治疗分析纳入2499名参与者(平均年龄27.1岁,标准差5.1;1488名(61.9%)女性)。与心理教育对照组相比,社会接触干预在干预后对感知康复产生了小幅但统计学显著的改善(调整后平均差[AMD] 0.201,95% CI 0.076-0.327;p = 0.0020)。在疏离感、刻板印象认同、保密或求助意向上,未出现显著的组间差异,且在Benjamini-Hochberg错误发现率校正后仍均不显著。在美国参与者中——唯一具有足够随访数据的站点——30天随访时感知康复未观察到显著组间差异(AMD 0.050,95% CI -0.306至0.407;p = 0.78),表明单次简短暴露不足以产生持久改变。与心理教育对照组相比,单次基于社会接触的视频未减少大多数自我污名维度,也未改善求助意向。需要更强化或更有针对性的方法,才能切实应对童年虐待幸存者的自我污名。SHN获得Azrieli基金会早期职业教师奖学金支持。美国的数据收集由NYSPI的自由研究经费资助。关于日本的数据收集,本工作由JSPS KAKENHI资助项目JP 23K02998支持。在南非,本研究由南非医学研究理事会脑疾病基因组学部门支持。其他国家的数据收集费用由参与机构/研究人员承担。
Ophthalmology IF 10.9 2026-10 PMID: 42229813
To investigate the potential association of semaglutide use and neovascular age-related macular degeneration (NVAMD). Retrospective study across 12 databases in the Observational Health Data Sciences and Informatics network from December 1, 2017, through December 31, 2024. Adults with type 2 diabetes (T2D) taking semaglutide, other glucagon-like peptide-1 receptor agonists (GLP-1RAs; e.g., dulaglutide or exenatide), or non-GLP-1RAs (e.g., empagliflozin, sitagliptin, or glipizide). The association between semaglutide use and NVAMD was assessed using 2 approaches: an active-comparator cohort design and a self-controlled case series analysis. The former used propensity score-adjusted Cox proportional hazards models to estimate hazard ratios (HRs). The latter used conditional Poisson regression models to estimate incidence rate ratios (IRRs). A random-effects meta-analysis was used to generate network-wide HR and IRR estimates. Two definitions of NVAMD, one based on condition codes alone (NVAMD-C) and one based on condition codes and procedures (NVAMD-CP). A total of 227 971 new users of semaglutide were included in the study. The risk of NVAMD among semaglutide users was similar to that of users of dulaglutide (NVAMD-C: HR, 0.57; 95% CI, 0.21-1.57; P = 0.28; NVAMD-CP: HR, 0.25; 95% CI, 0.05-1.27; P = 0.10), empagliflozin (NVAMD-C: HR, 0.98; 95% CI, 0.54-1.79; P = 0.94; NVAMD-CP: HR, 0.79; 95% CI, 0.38-1.64; P = 0.52), sitagliptin (NVAMD-C: HR, 2.08; 95% CI, 0.90-4.83; P = 0.09; NVAMD-CP: HR, 1.80; 95% CI, 0.55-5.86; P = 0.33), and glipizide (NVAMD-C: HR, 0.83; 95% CI, 0.35-2.02; P = 0.69; NVAMD-CP: HR, 0.50; 95% CI, 0.21-1.19; P = 0.12). No evidence was found of increased or decreased risk for NVAMD associated with semaglutide exposure (NVAMD-C: IRR, 0.92; 95% CI, 0.67-1.26; P = 0.60; NVAMD-CP: IRR, 1.02; 95% CI, 0.76-1.36; P = 0.92) nor with any of the other GLP-1RAs or non-GLP-1RAs. We detected no differences in the risk of NVAMD associated with semaglutide use among adults with T2D. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
中文摘要:旨在探讨司美格鲁肽使用与新生血管性年龄相关性黄斑变性(NVAMD)之间的潜在关联。本研究为回顾性研究,覆盖观察性健康数据科学与信息学网络中的12个数据库,时间范围为2017年12月1日至2024年12月31日。研究对象为正在使用司美格鲁肽、其他胰高血糖素样肽-1受体激动剂(GLP-1RAs,如度拉糖肽或艾塞那肽)或非GLP-1RAs(如恩格列净、西格列汀或格列吡嗪)的2型糖尿病(T2D)成人。采用两种方法评估司美格鲁肽使用与NVAMD之间的关联:一种为活性对照队列设计,另一种为自身对照病例系列分析。前者使用倾向评分校正的Cox比例风险模型估计风险比(HR)。后者使用条件泊松回归模型估计发病率比(IRR)。采用随机效应荟萃分析生成网络范围的HR和IRR估计值。NVAMD有两种定义:一种仅基于诊断代码(NVAMD-C),另一种基于诊断代码和操作(NVAMD-CP)。研究共纳入227 971名司美格鲁肽新使用者。司美格鲁肽使用者的NVAMD风险与度拉糖肽使用者相似(NVAMD-C:HR,0.57;95% CI,0.21-1.57;P = 0.28;NVAMD-CP:HR,0.25;95% CI,0.05-1.27;P = 0.10),与恩格列净使用者相似(NVAMD-C:HR,0.98;95% CI,0.54-1.79;P = 0.94;NVAMD-CP:HR,0.79;95% CI,0.38-1.64;P = 0.52),与西格列汀使用者相似(NVAMD-C:HR,2.08;95% CI,0.90-4.83;P = 0.09;NVAMD-CP:HR,1.80;95% CI,0.55-5.86;P = 0.33),与格列吡嗪使用者相似(NVAMD-C:HR,0.83;95% CI,0.35-2.02;P = 0.69;NVAMD-CP:HR,0.50;95% CI,0.21-1.19;P = 0.12)。未发现司美格鲁肽暴露与NVAMD风险升高或降低相关的证据(NVAMD-C:IRR,0.92;95% CI,0.67-1.26;P = 0.60;NVAMD-CP:IRR,1.02;95% CI,0.76-1.36;P = 0.92),也未发现其他任何GLP-1RAs或非GLP-1RAs存在这种关联。在2型糖尿病成人中,我们未检测到司美格鲁肽使用与NVAMD风险存在差异。专有或商业披露信息见本文末尾的脚注和披露部分。
Ophthalmology IF 10.9 2026-10 PMID: 42162762
To evaluate associations of risk factors with diabetic retinopathy (DR), diabetic macular edema (DME), and neural retinal layer thickness in youth with type 1 diabetes (T1D). Retrospective cross-sectional chart review study. Youth participants (< 22 years of age) with T1D from a tertiary diabetes center. Standardized record review of youth with T1D with clinic visits from 2005 through 2020. Spectral-domain (SD) macula scans were collected in a subset of patients, and automated retinal layer segmentation was performed for all retinal layers. Presence of DR and DME and retinal layer thickness. One thousand three hundred fifty-nine youth (2704 eyes) were included in this study; 49.6% female, mean age 13.7 ± 4.3 years, T1D duration 7.0 ± 5.2 years, T1D age of onset 7.7 ± 4.7 years, and HbA1c 8.4 ± 1.3%. Of eyes in this sample, 2565 (94.9%) had no DR and 139 (5.1%) had DR; 9 (0.3%) had DME. Older age, longer T1D duration, earlier T1D onset, higher HbA1c, and elevated/high BP were significantly associated with DR presence; these relationships remained significant in multivariable models that included age, sex, T1D duration, and HbA1c. In the 9 eyes with DME, it was associated with overweight/obese BMI. In 109 eyes (69 youth) with SDOCT imaging, and no DR, higher HbA1c was significantly associated with thinner central subfield thickness (CST), ganglion cell layer (GCL), and inner plexiform layer (IPL). Overweight/obese BMI was significantly associated with thicker retinal nerve fiber layer, GCL, and IPL. When correcting for multiple comparisons, higher HbA1c remained significantly associated with thinner CST and IPL. In this cohort, DR presence was associated with modifiable risk factors of worse glycemic control and higher BP. Higher HbA1c also was correlated with thinner CST and IPL, suggesting a possible association with retinal neurodegeneration. While DME was extremely rare, it may be associated with higher BMI. Although this cohort represents a recent population, it predates the latest innovations (e.g., automated insulin delivery) shaping diabetes management today. These findings support the potential importance of controlling modifiable systemic risk factors in diabetic eye disease in youth with T1D. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
中文摘要:评估1型糖尿病(T1D)青年中危险因素与糖尿病视网膜病变(DR)、糖尿病性黄斑水肿(DME)及视网膜神经层厚度的关联。回顾性横断面病历审查研究。参与者为来自一家三级糖尿病中心的1型糖尿病青年(<22岁)。对2005年至2020年期间有门诊就诊的1型糖尿病青年进行标准化病历审查。在部分患者中采集频域(SD)黄斑扫描,并对所有视网膜层进行自动视网膜层分割。观察指标为DR和DME的存在以及视网膜层厚度。本研究纳入1359名青年(2704只眼);49.6%为女性,平均年龄13.7±4.3岁,1型糖尿病病程7.0±5.2年,1型糖尿病发病年龄7.7±4.7岁,HbA1c 8.4±1.3%。在本样本的眼睛中,2565只(94.9%)无DR,139只(5.1%)有DR;9只(0.3%)有DME。年龄较大、1型糖尿病病程较长、发病年龄较早、HbA1c较高以及血压升高/高血压与DR存在显著相关;在纳入年龄、性别、1型糖尿病病程和HbA1c的多变量模型中,这些关系仍然显著。在9只有DME的眼睛中,DME与超重/肥胖BMI相关。在109只眼(69名青年)接受SDOCT成像且无DR者中,较高的HbA1c与较薄的中央子区厚度(CST)、神经节细胞层(GCL)和内丛状层(IPL)显著相关。超重/肥胖BMI与较厚的视网膜神经纤维层、GCL和IPL显著相关。在进行多重比较校正后,较高的HbA1c仍与较薄的CST和IPL显著相关。在该队列中,DR的存在与血糖控制较差和血压较高这两个可改变危险因素相关。较高的HbA1c还与较薄的CST和IPL相关,提示可能与视网膜神经退行性变有关。虽然DME极为罕见,但它可能与较高的BMI相关。尽管该队列代表了近期人群,但其时间早于当今塑造糖尿病管理的最新创新(例如自动胰岛素输注)。这些发现支持控制可改变的系统性危险因素在1型糖尿病青年糖尿病眼病中可能具有重要意义。专有或商业披露可在本文末尾的脚注和披露部分找到。

基础研究 (9篇)

Science advances IF 13.9 2026-10-09 PMID: 42842674
The retina metabolizes glucose into lactate, a hallmark of aerobic glycolysis known as the Warburg effect. Although evidence points to rod photoreceptors as the primary source of aerobic glycolysis, a comparison of the energy metabolism in different retinal neurons has yet to be performed. We combined two-photon fluorescence lifetime imaging of biosensors with pharmacological protocols to analyze metabolic dynamics in healthy and diseased rod photoreceptors and RBPMS-positive ganglion and calretinin-positive amacrine cells. Our data reveal distinct metabolic profiles among retinal neurons, identify rods as the drivers of aerobic glycolysis, demonstrate that inner retinal neurons rely on oxidative phosphorylation, show that rods need both glycolysis and oxidative phosphorylation to maintain ATP levels, and suggest that rods can metabolize lactate. A mutation causing retinitis pigmentosa increases lactate production in rods but changes the energy metabolism only subtly otherwise. Our results improve the understanding of retinal physiology and are relevant for pathologies involving imbalanced energy metabolism.
中文摘要:视网膜将葡萄糖代谢为乳酸,这是有氧糖酵解的一个标志,称为Warburg效应。尽管有证据表明视杆细胞是视网膜有氧糖酵解的主要来源,但尚未对不同视网膜神经元的能量代谢进行比较。我们结合生物传感器的双光子荧光寿命成像与药理学方案,分析健康和患病的视杆细胞以及RBPMS阳性神经节细胞和钙视网膜蛋白阳性无长突细胞的代谢动态。我们的数据揭示了视网膜神经元之间不同的代谢谱,确定视杆细胞是有氧糖酵解的驱动者,证明内层视网膜神经元依赖氧化磷酸化,表明视杆细胞需要糖酵解和氧化磷酸化来维持ATP水平,并提示视杆细胞可代谢乳酸。导致视网膜色素变性的突变增加了视杆细胞的乳酸生成,但除此之外仅轻微改变能量代谢。我们的结果增进了对视网膜生理学的理解,并与能量代谢失衡相关的病理有关。
Molecular biomedicine IF 13.0 2026-10-06 PMID: 42834249
Tractional retinal detachment caused by fibroproliferative membrane formation is a vision-threatening complication of proliferative diabetic retinopathy (PDR). Müller cells can acquire myofibroblast-like features during retinal fibroproliferative remodeling, yet the metabolic mechanisms governing these phenotypic changes remain poorly understood. Here, we report that lactate is a metabolic regulator of myofibroblast-like remodeling in Müller cells. Metabolomic profiling revealed elevated vitreous lactate levels in patients with PDR. Consistently, lactate concentrations were increased in the vitreous and retinal tissues of diabetic rats, whereas high-glucose exposure promoted lactate accumulation in primary Müller cells. Increased lactate availability enhanced Müller cell proliferative activity and migration, as well as the expression of myofibroblast-associated proteins, including α-smooth muscle actin, smooth muscle protein 22, and collagen I, whereas oxamate, an inhibitor of lactate dehydrogenase, attenuated these responses. Lactylome profiling and molecular validation revealed K186 of methyl-CpG-binding domain protein 2 (MBD2) as a functionally relevant lactylation site. RNA sequencing of high-glucose-treated Müller cells expressing MBD2-K186R versus MBD2-WT revealed reduced YAP1 expression in the K186R group, suggesting that YAP1 is a downstream effector of MBD2 K186 lactylation. Mechanistically, increased lactate availability enhanced MBD2 K186 lactylation and YAP1 activation, as evidenced by reduced inhibitory phosphorylation of YAP1 and increased nuclear accumulation of YAP1. MBD2 K186R attenuated YAP1 activation and myofibroblast-like changes, whereas YAP1 overexpression partially reversed these effects. Collectively, these findings reveal a lactate-MBD2 K186 lactylation-YAP1 signaling axis that promotes myofibroblast-like remodeling of Müller cells and may contribute to fibroproliferative pathology in PDR.
中文摘要:由纤维增生膜形成引起的牵拉性视网膜脱离是增生型糖尿病视网膜病变(PDR)的一种威胁视力的并发症。Müller细胞在视网膜纤维增生重塑过程中可获得肌成纤维细胞样特征,但调控这些表型改变的代谢机制仍知之甚少。在此,我们报道乳酸是Müller细胞肌成纤维细胞样重塑的一种代谢调节因子。代谢组学分析显示PDR患者玻璃体中乳酸水平升高。一致地,糖尿病大鼠玻璃体和视网膜组织中的乳酸浓度升高,而高糖暴露促进原代Müller细胞中乳酸积累。乳酸可利用性增加增强了Müller细胞的增殖活性和迁移,以及肌成纤维细胞相关蛋白的表达,包括α-平滑肌肌动蛋白、平滑肌蛋白22和I型胶原,而乳酸脱氢酶抑制剂草氨酸盐减弱了这些反应。乳酸化组分析和分子验证揭示甲基化CpG结合域蛋白2(MBD2)的K186是一个功能相关的乳酸化位点。对表达MBD2-K186R与MBD2-WT的高糖处理Müller细胞进行RNA测序,发现K186R组中YAP1表达降低,提示YAP1是MBD2 K186乳酸化的下游效应因子。机制上,乳酸可利用性增加增强了MBD2 K186乳酸化和YAP1激活,证据是YAP1的抑制性磷酸化降低以及YAP1核积累增加。MBD2 K186R减弱了YAP1激活和肌成纤维细胞样改变,而YAP1过表达部分逆转了这些效应。总之,这些发现揭示了一条乳酸-MBD2 K186乳酸化-YAP1信号轴,其促进Müller细胞的肌成纤维细胞样重塑,并可能促进PDR中的纤维增生性病理。
Acta biomaterialia IF 10.4 2026-10-01 PMID: 42822746
In aging and diseased retina, Bruch's membrane (BrM) stiffens heterogeneously, impairing phagocytic clearance of photoreceptor outer segments by the overlying retinal pigment epithelial (RPE) monolayer and contributing to retinal degeneration. While substrate stiffness is known to influence RPE phagocytosis, conventional assays lack the spatial resolution to capture how mechanical cues coordinate behavior across the monolayer over time. Here, dynamic magnetorheological elastomer (MRE) substrates are combined with an automated machine-learning image-analysis pipeline to simultaneously quantify particle engagement kinetics, cell morphology, and spatial organization at single-cell resolution. This combination enables spatiotemporal observation of RPE mechanosensitivity inaccessible to population-level assays. Substrate stiffness shaped particle engagement kinetics, modulating engagement rate and maximum particle capacity. Soft substrates additionally increased cell area and eccentricity, suggesting stiffness-dependent cytoskeletal remodeling. Strikingly, cells with increased levels of particle engagement form spatially localized clusters whose organization was sensitive to substrate stiffness, revealing that mechanical cues coordinate engagement behavior at the tissue level rather than acting on cells independently. This work reveals how dynamic BrM stiffening drives coupled changes in particle engagement kinetics, cell morphology, and spatial coordination, highlighting the tissue-level complexity of RPE mechanosensitivity. Together, these findings reframe RPE particle engagement as a spatially coordinated, mechanosensitive process, providing new insight into how dynamic alterations in extracellular mechanical environments regulate cellular function. STATEMENT OF SIGNIFICANCE: The retinal pigment epithelium (RPE) clears cellular debris daily to maintain vision, a process that falters as the underlying tissue stiffens with age, a hallmark of macular degeneration. Existing tools capture only population averages on static surfaces, obscuring both the timing and spatial organization of the response. This study combines dynamically tunable substrates with automated machine-learning image analysis to quantify receptor-mediated particle engagement at single-cell resolution across time and space. Mechanical transitions, not stiffness magnitude alone, accelerate engagement rate while reducing total capacity. Cell shape predicts particle engagement activity in a stiffness-dependent manner, and highly active cells cluster spatially in patterns governed by the mechanical environment. These findings reframe RPE dysfunction as a spatially coordinated, mechanosensitive process with direct implications for early AMD.
中文摘要:在衰老和患病的视网膜中,Bruch膜(BrM)发生异质性硬化,损害覆盖其上的视网膜色素上皮(RPE)单层对光感受器外段的吞噬清除,并促进视网膜变性。已知基底硬度会影响RPE吞噬作用,但传统实验缺乏空间分辨率,无法捕捉机械线索如何随时间协调整个单层的行为。在此,将动态磁流变弹性体(MRE)基底与自动化机器学习图像分析流程相结合,以单细胞分辨率同时量化颗粒结合动力学、细胞形态和空间组织。这一组合使得能够在群体水平实验无法实现的时空尺度上观察RPE机械敏感性。基底硬度塑造了颗粒结合动力学,调节结合速率和最大颗粒容量。软基底还增加了细胞面积和偏心率,提示存在硬度依赖的细胞骨架重塑。引人注目的是,颗粒结合水平升高的细胞形成空间定位的簇,其组织对基底硬度敏感,揭示机械线索在组织水平协调结合行为,而不是独立作用于细胞。这项工作揭示了动态BrM硬化如何驱动颗粒结合动力学、细胞形态和空间协调的耦合变化,突出RPE机械敏感性的组织水平复杂性。总之,这些发现将RPE颗粒结合重新定义为一种空间协调的机械敏感过程,为细胞外力学环境的动态改变如何调节细胞功能提供了新见解。意义声明:视网膜色素上皮(RPE)每天清除细胞碎片以维持视力,而随着底层组织衰老硬化,这一过程会衰退,这是黄斑变性的标志。现有工具只能捕捉静态表面上的群体平均值,掩盖了反应的时间和空间组织。本研究将动态可调基底与自动化机器学习图像分析相结合,以单细胞分辨率跨时间和空间量化受体介导的颗粒结合。机械转变而不仅是硬度大小,会加速结合速率,同时降低总容量。细胞形状以硬度依赖的方式预测颗粒结合活动,高活性细胞在受机械环境支配的模式中空间聚集。这些发现将RPE功能障碍重新定义为一种空间协调的机械敏感过程,对早期AMD具有直接意义。
MedComm IF 14.1 2026-10 PMID: 42756394
Dry age-related macular degeneration (AMD), affecting over 196 million people globally, represents the leading cause of irreversible blindness with limited disease-modifying therapies. The disease is characterized by progressive retinal pigment epithelium (RPE) degeneration driven by ferroptosis, an iron-dependent form of regulated cell death. While mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) show therapeutic promise, their mechanisms in counteracting RPE ferroptosis remain unexplored. Here, we prove that human umbilical cord MSC-derived EVs (hucMSC-EVs) significantly attenuate NaIO3-induced retinal degeneration, preserving retinal structure and improving visual function in mice. Transcriptomic profiling identified Lipocalin-2 (Lcn2) as a key ferroptosis-related target. MSC-EVs administration markedly downregulated Lcn2 and upregulated Gpx4 in NaIO3-induced models, demonstrating potent ferroptosis suppression. Furthermore, AAV-mediated Lcn2 overexpression induced AMD-like retinal pathology, which was effectively attenuated by subsequent MSC-EVs treatment. Small RNA sequencing reveals miR-486-3p as the key factor in the MSC-EVs, and dual-luciferase reporter assays confirm its direct binding to the Lcn2 3'UTR. Functional validation demonstrates that miR-486-3p agomir recapitulates the effects of MSC-EVs, including preservation of retinal structure and improvement of electrophysiological responses. Our findings establish a novel strategy where hucMSC-EVs deliver miR-486-3p to suppress Lcn2-mediated ferroptosis, offering a potential treatment for dry AMD.
中文摘要:干性年龄相关性黄斑变性(AMD)影响全球超过1.96亿人,是导致不可逆失明的主要原因,且有效改善疾病的疗法有限。该病以进行性视网膜色素上皮(RPE)变性为特征,由铁死亡驱动,铁死亡是一种铁依赖性调节性细胞死亡形式。虽然间充质干细胞(MSC)来源的细胞外囊泡(EVs)显示出治疗前景,但其对抗RPE铁死亡的机制尚未被探索。在此,我们证明人脐带MSC来源的EVs(hucMSC-EVs)可显著减轻NaIO3诱导的视网膜变性,保护小鼠视网膜结构并改善视觉功能。转录组分析确定Lipocalin-2(Lcn2)是关键铁死亡相关靶点。在NaIO3诱导的模型中,给予MSC-EVs可显著下调Lcn2并上调Gpx4,表明其具有强效铁死亡抑制作用。此外,AAV介导的Lcn2过表达可诱导AMD样视网膜病理,而随后的MSC-EVs治疗可有效减轻该病理。小RNA测序揭示miR-486-3p是MSC-EVs中的关键因子,双荧光素酶报告基因实验证实其直接结合Lcn2的3'UTR。功能验证表明,miR-486-3p agomir可重现MSC-EVs的作用,包括保护视网膜结构和改善电生理反应。我们的研究建立了一种新策略,即hucMSC-EVs递送miR-486-3p以抑制Lcn2介导的铁死亡,为干性AMD提供了潜在治疗方法。
Pharmacological research IF 12.2 2026-10 PMID: 42668075
Bile acids, as cholesterol metabolites, orchestrate a regulatory network with mitochondrial quality control through nuclear receptor FXR, membrane receptor TGR5, and other signaling molecules, modulating mitochondrial biogenesis, dynamic equilibrium, selective autophagy, and redox homeostasis. TGR5 promotes PGC-1α-mediated mitochondrial biogenesis via the cAMP-PKA-CREB pathway, while concurrently regulating mitochondrial fission and calcium homeostasis through the PKCδ/Drp1 and GRP75-MAMs pathways. FXR, acting through transcriptional reprogramming and epigenetic mechanisms, governs fatty acid oxidation, antioxidant defense, and apoptotic pathways, and has been shown to restore PINK1/Parkin-dependent autophagy and suppress NLRP3 inflammasome activation in alcoholic liver disease. Noncanonical receptors, including S1PR2, VDR, and PXR, also participate in the regulation of mitochondrial dynamics and autophagy. Dysregulation of this network is closely associated with metabolic dysfunction-associated fatty liver disease, diabetic retinopathy, pancreatic β-cells injury, alcoholic liver disease, and sepsis-induced immunoparalysis. Agonists targeting the aforementioned receptors, such as INT-777, INT-767, and Fexaramine, have demonstrated the capacity to restore mitochondrial function and alleviate tissue damage in animal models. Future investigations should employ multi-omics and structural biology approaches to elucidate receptor crosstalk and concentration-dependent bidirectional effects, and to develop tissue-selective modulators, thereby facilitating clinical translation.
中文摘要:胆汁酸作为胆固醇代谢产物,通过核受体FXR、膜受体TGR5及其他信号分子,与线粒体质量控制构成调控网络,调节线粒体生物发生、动态平衡、选择性自噬和氧化还原稳态。TGR5通过cAMP-PKA-CREB通路促进PGC-1α介导的线粒体生物发生,同时通过PKCδ/Drp1和GRP75-MAMs通路调控线粒体分裂和钙稳态。FXR通过转录重编程和表观遗传机制,调控脂肪酸氧化、抗氧化防御和凋亡通路,并已被证明可在酒精性肝病中恢复PINK1/Parkin依赖性自噬并抑制NLRP3炎症小体激活。非经典受体,包括S1PR2、VDR和PXR,也参与线粒体动力学和自噬的调控。该网络失调与代谢功能障碍相关脂肪性肝病、糖尿病视网膜病变、胰腺β细胞损伤、酒精性肝病以及脓毒症诱导的免疫麻痹密切相关。靶向上述受体的激动剂,如INT-777、INT-767和Fexaramine,已在动物模型中证明能够恢复线粒体功能并减轻组织损伤。未来研究应采用多组学和结构生物学方法,阐明受体串扰和浓度依赖性双向效应,并开发组织选择性调节剂,从而促进临床转化。
Redox biology IF 16.2 2026-10 PMID: 42641479
Age-related macular degeneration (AMD) is associated with mitochondrial dysfunction and oxidative stress, yet the relationship between mitochondrial remodeling, redox homeostasis, and disease progression remains poorly understood. Nonhuman primates (NHPs) develop spontaneous AMD-related phenotypes, including punctate deposits and soft drusen, providing a unique animal model to investigate mitochondrial pathology in the aging retinal pigment epithelium (RPE). We integrated quantitative mitochondrial ultrastructural profiling with flavoprotein fluorescence imaging, plasma metabolomics, and whole-exome sequencing to characterize mitochondrial and redox alterations in aged rhesus macaques with AMD-related lesions. Flavoprotein fluorescence imaging demonstrated increased metabolic heterogeneity in eyes with soft drusen, consistent with altered mitochondrial redox states and oxidative stress. Morphometric analysis identified distinct mitochondrial remodeling patterns across phenotypes. Normal aging was characterized by concentric cristae and type I paracrystalline inclusions. Eyes with punctate deposits exhibited increased mitochondrial fusion-associated morphology, hyperbranching, and type I paracrystalline inclusions, consistent with a stress-responsive mitochondrial remodeling pattern. In contrast, eyes with soft drusen exhibited reduced fusion-associated morphology, reduced structural complexity, and ultrastructural features consistent with mitochondrial deterioration. These ultrastructural patterns were accompanied by distinct plasma metabolomic signatures. Punctate deposits were associated with altered glycolytic, tricarboxylic acid cycle, and redox-buffering metabolites, consistent with differences in stress-responsive metabolism, whereas soft drusen exhibited metabolomic signatures consistent with altered redox homeostasis. Whole-exome sequencing identified a mitochondrial DNA variant, MT:9582G > A, in cytochrome c oxidase subunit III (COX3) associated with the drusen phenotype. Collectively, these findings identify distinct mitochondrial remodeling patterns associated with AMD-related phenotypes in aged rhesus macaques. The convergence of ultrastructural, imaging, metabolomic, and genetic analyses suggests that punctate deposits and soft drusen are associated with different mitochondrial and redox-related responses to chronic retinal stress. These findings provide a framework for future studies investigating mitochondrial biology and redox-driven mechanisms in AMD.
中文摘要:年龄相关性黄斑变性(AMD)与线粒体功能障碍和氧化应激有关,但线粒体重塑、氧化还原稳态与疾病进展之间的关系仍知之甚少。非人灵长类(NHP)可发生自发性AMD相关表型,包括点状沉积物和软性玻璃膜疣,为研究衰老视网膜色素上皮(RPE)中的线粒体病理提供了独特动物模型。我们将定量线粒体超微结构分析、黄素蛋白荧光成像、血浆代谢组学和全外显子组测序整合起来,以表征伴有AMD相关病变的老年恒河猴中的线粒体和氧化还原改变。黄素蛋白荧光成像显示,有软性玻璃膜疣的眼中代谢异质性增加,这与线粒体氧化还原状态改变和氧化应激一致。形态计量分析鉴定出不同表型间存在不同的线粒体重塑模式。正常衰老以同心嵴和I型副晶状包涵体为特征。有点状沉积物的眼表现出线粒体融合相关形态增多、过度分支和I型副晶状包涵体,符合应激反应性线粒体重塑模式。相反,有软性玻璃膜疣的眼表现出融合相关形态减少、结构复杂性降低以及符合线粒体退化的超微结构特征。这些超微结构模式伴随着不同的血浆代谢组学特征。点状沉积物与糖酵解、三羧酸循环和氧化还原缓冲代谢物的改变相关,符合应激反应性代谢差异,而软性玻璃膜疣则表现出符合氧化还原稳态改变的代谢组学特征。全外显子组测序在细胞色素c氧化酶亚基III(COX3)中鉴定出一个与玻璃膜疣表型相关的线粒体DNA变异MT:9582G > A。总之,这些发现确定了老年恒河猴中与AMD相关表型相关的不同线粒体重塑模式。超微结构、成像、代谢组学和遗传学分析的汇聚表明,点状沉积物和软性玻璃膜疣与慢性视网膜应激的不同线粒体和氧化还原相关反应有关。这些发现为未来研究AMD中的线粒体生物学和氧化还原驱动机制提供了框架。
Ageing research reviews IF 15.5 2026-10 PMID: 42586246
Retinal neurodegenerative diseases, such as age-related macular degeneration, diabetic retinopathy, glaucoma, and inherited retinal dystrophies, are major causes of irreversible vision loss worldwide. Although they originate from different causes, these disorders increasingly appear to share a network of cellular stress pathways, including impaired mitochondrial function, oxidative stress, endoplasmic reticulum proteostasis collapse, chronic neuroinflammation, epigenetic dysregulation, and activation of regulated cell death pathways. The interactions among these processes create an integrated stress network that gradually disrupts retinal homeostasis and promotes neuronal degeneration, which explains the failure of therapies targeting single molecular pathways. Nutraceutical compounds found in food are gaining interest as potential agents to support retinal health because many exhibit pleiotropic biological activities that influence mitochondrial function, inflammatory signaling, antioxidant defenses, and transcriptional regulation. Herein, we consolidate knowledge of the molecular mechanisms underlying retinal neurodegeneration and how major classes of nutraceuticals (polyphenols, carotenoids, omega-3 fatty acids, and metabolic modulators) may interact with these pathways. We also discuss key translational challenges in developing therapies, including poor bioavailability and differences between human phenotypes and model systems. Additionally, we highlight emerging concepts such as microbiome-dependent metabolism of nutraceuticals, personalized nutrition strategies, and advanced ocular drug-delivery technologies. Collectively, these findings support a systems-level framework in which selected nutraceuticals may influence multiple nodes of retinal stress biology, although clinical validation remains limited.
中文摘要:视网膜神经退行性疾病,如年龄相关性黄斑变性、糖尿病视网膜病变、青光眼和遗传性视网膜营养不良,是全球不可逆视力丧失的主要原因。尽管这些疾病起因不同,但日益显现出它们共享一个细胞应激通路网络,包括线粒体功能受损、氧化应激、内质网蛋白质稳态崩溃、慢性神经炎症、表观遗传失调以及受调控细胞死亡通路的激活。这些过程之间的相互作用形成一个整合的应激网络,逐渐破坏视网膜稳态并促进神经元变性,这解释了针对单一分子通路的治疗为何失败。食物中发现的营养保健品化合物作为支持视网膜健康的潜在制剂正受到关注,因为许多表现出多效性生物活性,可影响线粒体功能、炎症信号、抗氧化防御和转录调控。本文中,我们整合了关于视网膜神经退行性变分子机制的知识,以及主要营养保健品类别(多酚、类胡萝卜素、omega-3脂肪酸和代谢调节剂)可能如何与这些通路相互作用。我们还讨论了开发治疗中的关键转化挑战,包括生物利用度差以及人类表型与模型系统之间的差异。此外,我们强调了新兴概念,如营养保健品的微生物组依赖性代谢、个性化营养策略和先进的眼部药物递送技术。总体而言,这些发现支持一个系统级框架,其中选定的营养保健品可能影响视网膜应激生物学的多个节点,尽管临床验证仍然有限。
Diabetologia IF 10.4 2026-10 PMID: 42576031
Leukocyte cell-derived chemotaxin 2 (LECT2), a newly discovered hepatokine involved in immunomodulation and inflammatory processes, has recently been implicated in diabetic retinopathy pathogenesis. However, the specific role and mechanism of LECT2 in diabetic retinopathy remain largely unclear. A publicly available liquid biopsy proteomics dataset was reanalysed and validated using retinal samples from individuals with diabetic retinopathy. A LECT2-knockdown (Lect2+/-) mouse model of diabetic retinopathy was established to evaluate the role of LECT2 in vivo. Retinal pathology was assessed by Periodic Acid-Schiff staining and H&E staining, and LECT2 expression was assessed by western blotting. In parallel, a high glucose (HG)-induced human Müller cell model was used to investigate the subcellular localisation and functional effects of LECT2. LECT2 expression and inflammatory signalling were analysed following LECT2 knockdown or overexpression, and its nucleus-cytoplasm distribution was examined by fractionation assays. The interaction between LECT2 and ribosomal protein S27a (RPS27A) was characterised by immunoprecipitation-MS, co-immunoprecipitation, molecular docking and split-GFP assays, followed by RPS27A silencing to assess its effects on inflammatory protein expression. Proteomic reanalysis of proliferative diabetic retinopathy liquid biopsy data identified 1479 upregulated proteins, with chemotaxis among the most significantly enriched Gene Ontology terms (false discovery rate <0.001). Among 17 chemotaxis-related candidate proteins, LECT2 emerged as a potential regulator of diabetes-associated inflammation, a finding further supported by its elevated expression in the retinas of individuals with diabetic retinopathy. In diabetic Lect2+/- mice, LECT2 deficiency aggravated retinal microvascular injury and inflammatory responses. LECT2 was predominantly expressed in retinal Müller cells, implicating it in glia-associated retinal inflammation. In HG-treated human retinal Müller cells, RPS27A was identified as a downstream target of LECT2 and was upregulated under hyperglycaemic conditions. Mechanistically, HG stimulation increased the expression and nuclear accumulation of both LECT2 and RPS27A. LECT2 interacted with RPS27A at the Lys48 site, promoting its nuclear retention and limiting its cytoplasmic translocation. This, in turn, inhibited IκBα ubiquitination and degradation, thereby suppressing NF-κB-driven inflammatory signalling. Taken together, our studies indicated the protective role of LECT2 in diabetes-induced dysfunction of retinal Müller cells, supporting the feasibility of targeting LECT2 in the management of diabetic inflammation and microvasculopathy.
中文摘要:白细胞细胞来源趋化因子2(LECT2)是一种新发现的参与免疫调节和炎症过程的肝因子,近期被认为与糖尿病视网膜病变发病机制有关。然而,LECT2在糖尿病视网膜病变中的具体作用和机制在很大程度上仍不清楚。我们对一个公开可用的液体活检蛋白质组学数据集进行了再分析,并使用糖尿病视网膜病变患者的视网膜样本进行了验证。建立LECT2敲低(Lect2+/-)糖尿病视网膜病变小鼠模型,以评估LECT2在体内的作用。通过过碘酸-雪夫染色和H&E染色评估视网膜病理,通过蛋白质印迹评估LECT2表达。同时,使用高糖(HG)诱导的人Müller细胞模型研究LECT2的亚细胞定位和功能效应。在LECT2敲低或过表达后分析LECT2表达和炎症信号传导,并通过组分分离实验检查其细胞核-细胞质分布。通过免疫沉淀-质谱、免疫共沉淀、分子对接和split-GFP实验表征LECT2与核糖体蛋白S27a(RPS27A)之间的相互作用,随后沉默RPS27A以评估其对炎症蛋白表达的影响。对增殖性糖尿病视网膜病变液体活检数据的蛋白质组学再分析鉴定出1479个上调蛋白,其中趋化性是最显著富集的基因本体术语之一(错误发现率<0.001)。在17个趋化性相关候选蛋白中,LECT2显现为糖尿病相关炎症的潜在调节因子,其在糖尿病视网膜病变患者视网膜中表达升高进一步支持了这一发现。在糖尿病Lect2+/-小鼠中,LECT2缺乏加重了视网膜微血管损伤和炎症反应。LECT2主要表达于视网膜Müller细胞,提示其参与胶质细胞相关视网膜炎症。在高糖处理的人视网膜Müller细胞中,RPS27A被鉴定为LECT2的下游靶点,并在高血糖条件下上调。机制上,高糖刺激增加了LECT2和RPS27A的表达及核内积累。LECT2在Lys48位点与RPS27A相互作用,促进其核内滞留并限制其细胞质转位。这反过来抑制了IκBα泛素化和降解,从而抑制NF-κB驱动的炎症信号传导。总之,我们的研究表明LECT2在糖尿病诱导的视网膜Müller细胞功能障碍中具有保护作用,支持靶向LECT2用于管理糖尿病炎症和微血管病变的可行性。
Biomaterials IF 13.6 2026-10 PMID: 41936183
Oxidative stress-induced retinal pigment epithelium (RPE) degeneration is the pathologic basis of most retinal degenerative diseases, especially dry age-related macular degeneration (AMD), for which corresponding therapeutic strategies currently were still in their infancy and lack optimal efficacy. In the present study, cerium-doped molybdenum-based polyoxometalate (MoCe) nanoclusters (NCs) are designed as antioxidative nanocatalysts to inhibit oxidative stress-induced RPE degeneration and subsequent retinal damage. The synthesized MoCe NCs display prominent reactive oxygen species (ROS) scavenging efficacy with excellent in vivo biocompatibility. In RPE degeneration mice model, a single intravitreal administration of MoCe NCs effectively inhibit RPE oxidative degeneration and substantially protect retinal structure and visual function. Upon high-throughput sequencing combined with bioinformatics analysis, MoCe administration predominantly restores the expression of DNA repair-related genes and inhibits oxidative stress-induced apoptosis by suppressing the JNK/c-Jun signaling pathway. The ideal biocompatibility and remarkable protective effect render MoCe NCs as the promising nanomedicines combating RPE degeneration-associated retinal diseases especially AMD.
中文摘要:氧化应激诱导的视网膜色素上皮(RPE)退变是大多数视网膜退行性疾病的病理基础,尤其是干性年龄相关性黄斑变性(AMD),而目前相应的治疗策略仍处于起步阶段,缺乏最佳疗效。在本研究中,设计了铈掺杂的钼基多金属氧酸盐(MoCe)纳米簇(NCs)作为抗氧化纳米催化剂,以抑制氧化应激诱导的RPE退变及随后的视网膜损伤。合成的MoCe NCs表现出显著的活性氧(ROS)清除功效,并具有良好的体内生物相容性。在RPE退变小鼠模型中,单次玻璃体内注射MoCe NCs可有效抑制RPE氧化性退变,并显著保护视网膜结构和视觉功能。通过高通量测序结合生物信息学分析,MoCe给药主要恢复DNA修复相关基因的表达,并通过抑制JNK/c-Jun信号通路来抑制氧化应激诱导的细胞凋亡。理想的生物相容性和显著的保护作用使MoCe NCs成为对抗RPE退变相关视网膜疾病尤其是AMD的有前景的纳米药物。

2青光眼 (6篇)

临床研究 (4篇)

Ophthalmology IF 10.9 2026-10-07 PMID: 42841846
To evaluate the recently published literature on the efficacy and safety outcomes of delivering mitomycin C (MMC) by either sub-Tenon's/subconjunctival injection (MMC-I) or by sponge (MMC-S) during trabeculectomy surgery. A literature search was last conducted in the PubMed database in May 2026 and yielded 135 articles. Eighteen full-text articles were reviewed, and 11 met all inclusion criteria for this assessment and were assigned a level of evidence rating by the panel methodologist. Six studies were rated level I, 2 were rated level II, and 3 were rated level III. The racial and ethnic backgrounds of study participants represented a diverse mix, and in many studies, a variety of glaucoma diagnoses were included, the majority of which were primary open-angle glaucoma. The MMC-I technique was reported to have used a wider range of drug concentrations (0.05-0.4 mg/mL) than MMC-S (0.1-0.4 mg/mL). The complete success rate of intraocular pressure (IOP) control ranged from 40.3% to 90.9% in the MMC-I group compared with 17.7% to 86.5% in the MMC-S group. The wide range of success rates may be a result of differences in definitions of success, follow-up time, and patient populations. Change in IOP from baseline ranged from 2.8 mmHg (17%) to 19.4 mmHg (58%) in the MMC-I group compared with 5.8 mmHg (31%) to 18.0 mmHg (59%) in the MMC-S group. No significant differences in complications, such as rates of bleb leak, hypotony, choroidal effusion, or choroidal hemorrhage, were reported. Two studies reported significantly fewer 5-fluorouracil injections in the MMC-I group, and 1 reported more glaucoma surgery reoperations in the MMC-S group. Several studies reported a more favorable bleb morphology that was diffuse, lower profile, and less vascular in the MMC-I group than in the MMC-S group. Although MMC-I may offer some advantages over MMC-S trabeculectomy with respect to bleb morphology, level I and II evidence supports the application of MMC using either injection or sponges during trabeculectomy. Both applications result in similar rates of surgical success (a lower IOP and a reduction in medication burden) and have a similar safety profile. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
中文摘要:评估近期发表的关于在小梁切除术中通过Tenon囊下/结膜下注射(MMC-I)或海绵(MMC-S)递送丝裂霉素C(MMC)的疗效和安全性结局的文献。最后一次文献检索于2026年5月在PubMed数据库进行,共获得135篇文章。审阅了18篇全文文章,其中11篇符合本评估的所有纳入标准,并由小组方法学家进行证据等级评定。6项研究被评为I级,2项为II级,3项为III级。研究参与者的种族和民族背景呈现多样化,许多研究纳入了多种青光眼诊断,其中大多数为原发性开角型青光眼。据报道,MMC-I技术使用的药物浓度范围(0.05-0.4 mg/mL)比MMC-S(0.1-0.4 mg/mL)更广。MMC-I组眼压(IOP)控制的完全成功率范围为40.3%至90.9%,而MMC-S组为17.7%至86.5%。成功率范围较宽可能是由于成功定义、随访时间和患者人群的差异。MMC-I组眼压较基线的变化范围为2.8 mmHg(17%)至19.4 mmHg(58%),而MMC-S组为5.8 mmHg(31%)至18.0 mmHg(59%)。未报告并发症方面的显著差异,如滤过泡渗漏、低眼压、脉络膜渗出或脉络膜出血的发生率。两项研究报告MMC-I组的5-氟尿嘧啶注射次数显著更少,1项研究报告MMC-S组的青光眼手术再手术次数更多。多项研究报告MMC-I组的滤过泡形态更有利,表现为弥漫、低平且血管更少。尽管MMC-I在小梁切除术的滤过泡形态方面可能较MMC-S具有一定优势,但I级和II级证据支持在小梁切除术中使用注射或海绵方式应用MMC。两种应用方式导致相似的手术成功率(更低的眼压和药物负担减少)和相似的安全性特征。专有或商业披露可在本文末尾的脚注和披露中找到。
Cancer research IF 22.6 2026-10-02 PMID: 42391342
Intrinsic and acquired resistance to CDK4/6 inhibitors (CDK4/6i) is a critical challenge in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC). CDK2 inhibitors (CDK2i) show promise in this context, with several currently under early-phase clinical evaluation. In this study, by analyzing tumor and liquid biopsies from patients treated with the selective CDK2i PF-07104091, we observed that PF-07104091 monotherapy achieved disease stabilization in a cohort of patients with CDK4/6i-resistant HR+/HER2- MBC. Notably, responses were observed irrespective of retinoblastoma (RB) expression and phosphorylation, whereas nonprogressive disease appeared more frequently among patients whose tumors retained wild-type TP53. Studies in established and patient-derived cell lines further substantiated that the growth-suppressive effects of CDK2i were independent of RB status in CDK4/6i-resistant models. CDK2i activity reduced the DNA replication rate, increased DNA damage, and inhibited mitotic entry, with growth inhibition dependent on p53 expression. These findings indicate that CDK dependency shifts from CDK4/6 toward CDK2 as cells transition from a CDK4/6i-sensitive to a CDK4/6i-resistant state. The distinct mechanisms of CDK2i and CDK4/6i support enhanced synergistic activity in HR+/HER2- MBC with acquired resistance to CDK4/6i therapy. Integrated analysis of CDK2 inhibitor-treated patients and experimental models reveals RB1-independent and p53-dependent mechanisms of CDK2 inhibition in breast cancer, supporting biomarker-guided therapeutic strategies and rational combination approaches.
中文摘要:CDK4/6抑制剂(CDK4/6i)的原发性和获得性耐药是激素受体阳性(HR+)、人表皮生长因子受体2阴性(HER2-)转移性乳腺癌(MBC)中的关键挑战。CDK2抑制剂(CDK2i)在此背景下显示出前景,目前有多种药物正处于早期临床评估阶段。在本研究中,通过分析接受选择性CDK2i PF-07104091治疗患者的肿瘤和液体活检,我们观察到PF-07104091单药治疗在一组CDK4/6i耐药HR+/HER2- MBC患者中实现了疾病稳定。值得注意的是,缓解与视网膜母细胞瘤(RB)表达和磷酸化无关,而非进展性疾病在肿瘤保留野生型TP53的患者中似乎更常见。在已建立细胞系和患者来源细胞系中的研究进一步证实,在CDK4/6i耐药模型中,CDK2i的生长抑制作用不依赖于RB状态。CDK2i活性降低了DNA复制速率,增加了DNA损伤,并抑制了有丝分裂进入,其生长抑制依赖于p53表达。这些发现表明,随着细胞从CDK4/6i敏感状态转变为CDK4/6i耐药状态,CDK依赖性从CDK4/6转向CDK2。CDK2i与CDK4/6i的不同机制支持在获得性CDK4/6i治疗耐药的HR+/HER2- MBC中增强协同活性。对接受CDK2抑制剂治疗的患者和实验模型的整合分析,揭示了乳腺癌中CDK2抑制的RB1非依赖和p53依赖机制,支持生物标志物指导的治疗策略和合理的联合方案。
Ophthalmology IF 10.9 2026-10 PMID: 42134554
To evaluate the effect of a single intraoperative dose of intravitreal bevacizumab (Avastin) on surgical success after trabeculectomy with mitomycin-C (MMC) over 3 years. Single-center, parallel, double-masked, randomized, placebo-controlled trial. The setting was a single ophthalmic outpatient referral center within a tertiary teaching hospital. Patients requiring primary or redo trabeculectomy or phacotrabeculectomy for progressing glaucoma. Patients were randomized to a single intraoperative intravitreal injection of Avastin (1.25 mg in 0.05 mL) or placebo (balanced salt solution 0.05 mL). The primary outcome was treatment success, which was defined by "complete success" when intraocular pressure (IOP) remained less than a predefined target IOP without the requirement of topical medication or "qualified success" when topical medication was required to meet the predefined target IOP threshold. From a total of 131 patients randomized to bevacizumab (Avastin; n = 65) or placebo (n = 66), 111 patients completed 36 months of follow-up (85%). At 36 months, trabeculectomy survival was higher in the bevacizumab cohort (hazard ratio [complete success] = 0.17, P = 0.002; [qualified success] = 0.07, P = 0.03). Within the placebo cohort, the requirement for topical therapy was higher at 3 months (P = 0.008), 6 months (P = 0.009), 12 months (P = 0.007), and 36 months (P < 0.005). Bevacizumab was given as a single intravitreal dose during trabeculectomy with MMC resulting in improved surgical success at 36 months postoperatively. The author(s) have no proprietary or commercial interest in any materials discussed in this article.
中文摘要:评估术中单次玻璃体内注射贝伐珠单抗(Avastin)对联合丝裂霉素C(MMC)的小梁切除术后3年手术成功率的影响。单中心、平行组、双盲、随机、安慰剂对照试验。研究地点为一家三级教学医院内的单一眼科门诊转诊中心。纳入因青光眼进展而需行初次或再次小梁切除术或超声乳化联合小梁切除术的患者。患者被随机分配至术中单次玻璃体内注射Avastin(1.25 mg/0.05 mL)或安慰剂(平衡盐溶液0.05 mL)。主要结局为治疗成功,定义为:在不需局部降眼压药物的情况下眼压(IOP)持续低于预设目标眼压,即「完全成功」;或在需要局部药物才能达到预设目标眼压阈值的情况下,即「合格成功」。共有131例患者随机分配至贝伐珠单抗组(Avastin;n=65)或安慰剂组(n=66),其中111例患者完成36个月随访(85%)。在36个月时,贝伐珠单抗组的小梁切除术生存率更高(风险比[完全成功]=0.17,P=0.002;[合格成功]=0.07,P=0.03)。在安慰剂组内,需要局部治疗的比例在3个月(P=0.008)、6个月(P=0.009)、12个月(P=0.007)和36个月(P<0.005)时更高。在联合MMC的小梁切除术中单次玻璃体内给予贝伐珠单抗,使术后36个月的手术成功率得到改善。作者声明对本文讨论的任何材料均无专有或商业利益。
Ophthalmology IF 10.9 2026-10 PMID: 42097331
To evaluate the individual and combined diagnostic performance of cytokine, molecular, and clonality biomarkers for primary vitreoretinal lymphoma (PVRL). Systematic review and meta-analysis. A total of 2411 patients from 41 studies with confirmed PVRL or benign ocular inflammatory diseases. Prospectively registered (CRD420251265910). Four databases were searched through November 25, 2025. Methodologic quality was assessed using QUADAS-2 and Comparative tools. Diagnostic accuracy was pooled using hierarchical summary receiver operating characteristic (HSROC) models with GRADE certainty assessment. Pooled sensitivity, specificity, and AUSROC for each biomarker with GRADE certainty ratings. Of 41 included studies, most were rated at high or unclear risk of bias across Quality Assessment of Diagnostic Accuracy Studies 2 domains, predominantly in patient selection because of retrospective designs and nonconsecutive sampling, and in the index test domain because of post hoc threshold selection. The interleukin (IL)-10 to IL-6 ratio (27 studies; 1370 patients; AUSROC, 0.98; sensitivity, 0.89; specificity, 0.98; I2 = 61% and 69%, respectively; low certainty) showed no publication bias. MYD88 (12 studies; 382 patients; AUSROC, 0.89; sensitivity, 0.73, specificity, 0.99; I2 = 37% and 68%, respectively; very low certainty), IGH (12 studies; 649 patients; AUSROC, 0.97; sensitivity, 0.85, specificity, 0.97; I2 = 80% and 87%, respectively; very low certainty), and IL-10 alone (11 studies; 549 patients; AUSROC, 0.94; sensitivity, 0.87, specificity, 0.95; I2 = 58% and 84%, respectively; low certainty) did not outperform IL-10 and IL-6 statistically. CD79B (4 studies; 123 patients; AUSROC, 1.00; sensitivity, 0.40; specificity, 1.00; I2 = 35% and 0%, respectively; low certainty) showed numerically higher accuracy (P = 0.055). Parallel testing of IL-10 to IL-6 ratio and MYD88 achieved 97.1% sensitivity and 97.0% specificity, reducing false-negative rates from 11% to 2.9%. Parallel testing of IL-10 to IL-6 ratio and MYD88 seemed to offer the highest diagnostic performance among evaluated strategies for PVRL, although this finding requires prospective validation given the low to very low certainty of the underlying evidence. Aqueous humor cytokine testing yielded higher diagnostic odds ratios than vitreous fluid, suggesting anterior paracentesis for IL-10 to IL-6 ratio before vitreous biopsy for molecular confirmation. The author(s) have no proprietary or commercial interest in any materials discussed in this article.
中文摘要:旨在评估细胞因子、分子和克隆性生物标志物对原发性玻璃体视网膜淋巴瘤(PVRL)的单独及联合诊断效能。系统评价与荟萃分析。共纳入41项研究中的2411例患者,这些患者确诊为PVRL或良性眼部炎性疾病。研究前瞻性注册(CRD420251265910)。检索了四个数据库,截止日期为2025年11月25日。使用QUADAS-2和Comparative工具评估方法学质量。采用分层汇总受试者工作特征(HSROC)模型合并诊断准确性,并进行GRADE证据确定性评估。报告每种生物标志物的汇总敏感性、特异性和AUSROC及其GRADE证据确定性评级。在41项纳入研究中,多数在诊断准确性研究质量评价2(QUADAS-2)各领域被评为高偏倚风险或不明确偏倚风险,主要见于患者选择领域,原因包括回顾性设计和非连续抽样;以及指数试验领域,原因包括事后阈值选择。白细胞介素(IL)-10与IL-6比值(27项研究;1370例患者;AUSROC为0.98;敏感性为0.89;特异性为0.98;I2分别为61%和69%;低确定性)未显示发表偏倚。MYD88(12项研究;382例患者;AUSROC为0.89;敏感性为0.73,特异性为0.99;I2分别为37%和68%;极低确定性)、IGH(12项研究;649例患者;AUSROC为0.97;敏感性为0.85,特异性为0.97;I2分别为80%和87%;极低确定性)以及单独IL-10(11项研究;549例患者;AUSROC为0.94;敏感性为0.87,特异性为0.95;I2分别为58%和84%;低确定性)在统计学上未优于IL-10与IL-6。CD79B(4项研究;123例患者;AUSROC为1.00;敏感性为0.40;特异性为1.00;I2分别为35%和0%;低确定性)显示出数值上更高的准确性(P = 0.055)。IL-10与IL-6比值和MYD88平行检测达到97.1%的敏感性和97.0%的特异性,将假阴性率从11%降至2.9%。在针对PVRL的受评估策略中,IL-10与IL-6比值和MYD88的平行检测似乎具有最高的诊断效能,但鉴于基础证据的确定性为低至极低,该发现仍需前瞻性验证。房水细胞因子检测产生的诊断比值比高于玻璃体液,提示可在玻璃体活检进行分子确认之前先行前房穿刺以检测IL-10与IL-6比值。作者声明对本文讨论的任何材料均无专有或商业利益。

基础研究 (2篇)

Acta biomaterialia IF 10.4 2026-10 PMID: 42648685
Postoperative scarring and failure of surgically created drainage pathways limit durable glaucoma surgery. We developed a solid plate-type suprachoroidal space (SCS) implant based on hydroxyapatite-coated magnesium (HA-Mg) to provide temporary pathway support, an HA-modified material-tissue interface, and progressive biodegradation. TGF-β2-stimulated human iris pigment epithelial cells were used to assess material-associated effects on migration and fibrotic activation. In a paired-eye normotensive New Zealand White rabbit model, trabeculectomy, sham SCS surgery, titanium, uncoated magnesium, and HA-Mg groups were evaluated for 24 weeks using intraocular pressure (IOP) monitoring, ex vivo SCS angiography, micro-computed tomography, histology, α-smooth muscle actin (α-SMA) immunofluorescence, corneal endothelial assessment, aqueous humor pH, and systemic safety analyses. HA-Mg produced a sustained, stable IOP-lowering profile, whereas both Mg and HA-Mg showed greater net IOP reduction at Week 24 than the other surgically treated groups. HA-Mg showed broader posterior SCS contrast enhancement at Weeks 12 and 24. From Week 4 to Week 24, residual implant volume and surface area decreased by 93.6% and 86.3%, respectively, although residual material remained. Histology and α-SMA analysis were consistent with reduced fibrosis-associated interface remodeling, and Mg and HA-Mg extracts attenuated TGF-β2-induced migration and α-SMA expression. No evident ocular or systemic safety concerns were detected within 24 weeks. HA-Mg therefore supported medium-term preservation of the surgically created SCS outflow pathway while undergoing substantial but incomplete degradation; longer-term studies extending through and beyond complete implant resorption are required to determine whether pathway patency and safety are maintained thereafter. STATEMENT OF SIGNIFICANCE: Glaucoma drainage surgery remains limited by progressive fibrosis, foreign-body responses, and loss of long-term drainage pathway function. Although suprachoroidal space (SCS) approaches provide an alternative aqueous outflow route, maintaining pathway patency while minimizing the burden of permanent implants remains challenging. Here, we developed a biodegradable hydroxyapatite-coated magnesium (HA-Mg) drainage plate designed to provide temporary structural support and gradually degrade during tissue remodeling. The study integrates material characterization, medium-term in vivo evaluation, degradation tracking, fibrosis-associated remodeling assessment, and biosafety analysis in a rabbit model. Our findings support a biomaterial strategy that couples progressive biodegradation with preservation of SCS outflow-associated function, providing a potential framework for next-generation biodegradable implants in glaucoma surgery and other applications requiring temporary tissue-implant interfaces.
中文摘要:术后瘢痕形成及手术创建的引流通道失败限制了持久有效的青光眼手术。我们开发了一种基于羟基磷灰石涂层镁(HA-Mg)的实体板状脉络膜上腔(SCS)植入物,以提供临时通道支撑、羟基磷灰石修饰的材料-组织界面以及逐步生物降解。使用TGF-β2刺激的人虹膜色素上皮细胞评估材料对迁移和纤维化激活的相关影响。在双眼配对、眼压正常的新西兰白兔模型中,对小鼠小梁切除术、假SCS手术、钛、未涂层镁和HA-Mg组进行24周评估,评估方法包括眼压(IOP)监测、离体SCS血管造影、微型计算机断层扫描、组织学、α-平滑肌肌动蛋白(α-SMA)免疫荧光、角膜内皮评估、房水pH以及全身安全性分析。HA-Mg产生了持续、稳定的降眼压特征,而Mg和HA-Mg在第24周时均显示出比其他手术治疗组更大的净眼压降低。HA-Mg在第12周和第24周显示出更广泛的后部SCS对比增强。从第4周到第24周,残余植入物体积和表面积分别减少93.6%和86.3%,尽管仍有残留材料。组织学和α-SMA分析与纤维化相关界面重塑减少一致,且Mg和HA-Mg提取物减弱了TGF-β2诱导的迁移和α-SMA表达。在24周内未检测到明显眼部或全身安全性问题。因此,HA-Mg支持在发生显著但不完全降解的同时,中期保留手术创建的SCS流出通道;需要延长至植入物完全吸收及之后更长期的研究,以确定此后通道通畅性和安全性是否得以维持。意义声明:青光眼引流手术仍受到进行性纤维化、异物反应和长期引流通道功能丧失的限制。尽管脉络膜上腔(SCS)方法提供了替代的房水流出途径,但如何在维持通道通畅的同时尽量减少永久性植入物负担仍具挑战性。在此,我们开发了一种可生物降解的羟基磷灰石涂层镁(HA-Mg)引流板,旨在提供临时结构支撑并在组织重塑过程中逐渐降解。该研究在兔模型中整合了材料表征、中期体内评估、降解追踪、纤维化相关重塑评估和生物安全性分析。我们的发现支持一种将逐步生物降解与SCS流出相关功能保留相结合的生物材料策略,为青光眼手术及其他需要临时组织-植入物界面的应用中的下一代可生物降解植入物提供了潜在框架。
Bioactive materials IF 23.6 2026-10 PMID: 42093835
Effective treatment of bacterial keratitis is constrained by poor ocular drug bioavailability and tissue damage caused by bacterial invasion and the subsequent host inflammatory response. Motivated by molecular insights into the high mobility group box 1 (HMGB1)-driven neutrophil inflammatory amplification loop, a reactive oxygen species (ROS)-responsive poly (vinyl alcohol) (PVA) hydrogel eyedrops (TPG@OC) was developed to integrate deep corneal antibacterial delivery with immune microenvironment modulation. The hydrogel framework was functionalized with glycyrrhizin acid to neutralize extracellular HMGB1, while cornea-penetrating poly (2- (N-oxide-N, N-diethylamino)) ethyl methacrylate (OPDEA) micelles loaded with ciprofloxacin (OC) enable efficient transcytosis-mediated delivery into the deep corneal stroma. In a murine Pseudomonas aeruginosa keratitis model, TPG@OC exhibited prolonged ocular retention, enhanced corneal penetration, and potent antibacterial efficacy, while effectively suppressing ROS accumulation, neutrophil infiltration, extracellular traps formation, and pro-inflammatory cytokine release, thereby interrupting the HMGB1-mediated inflammatory feedback loop. Notably, therapeutic evaluations in a rabbit keratitis model revealed that TPG@OC treatment extended beyond anti-infective efficacy to preserve corneal biomechanical stability, evidenced by relatively regular corneal curvature, alleviated stromal thickening, and substantially reduced deformation under intraocular pressure predicted by finite element analysis. Collectively, this work establishes a dual-pronged hydrogel platform that couples deep antimicrobial delivery with HMGB1-targeted immunoregulation to preserve corneal transparency and biomechanical integrity, offering a promising materials-based strategy for infectious keratitis therapy.
中文摘要:细菌性角膜炎的有效治疗受到眼部药物生物利用度低以及细菌侵袭和随后宿主炎症反应所致组织损伤的限制。基于对高迁移率族蛋白B1(HMGB1)驱动中性粒细胞炎症放大环路的分子认识,本研究开发了一种活性氧(ROS)响应性聚乙烯醇(PVA)水凝胶眼药水(TPG@OC),以整合深部角膜抗菌递送与免疫微环境调控。该水凝胶框架经甘草酸功能化以中和细胞外HMGB1,而负载环丙沙星的角膜穿透性聚(2-(N-氧化物-N,N-二乙氨基)乙基甲基丙烯酸酯)(OPDEA)胶束(OC)可通过转胞吞作用高效递送至深部角膜基质。在小鼠铜绿假单胞菌角膜炎模型中,TPG@OC表现出延长的眼部滞留、增强的角膜穿透和强效抗菌作用,同时有效抑制ROS积累、中性粒细胞浸润、胞外陷阱形成和促炎细胞因子释放,从而中断HMGB1介导的炎症反馈环路。值得注意的是,在兔角膜炎模型中的治疗评价显示,TPG@OC治疗不仅具有抗感染效果,还可维持角膜生物力学稳定性,表现为角膜曲率相对规则、基质增厚减轻,以及有限元分析预测的眼内压作用下变形显著减少。总体而言,本研究建立了一种双管齐下的水凝胶平台,将深部抗菌递送与靶向HMGB1的免疫调节相结合,以保持角膜透明度和生物力学完整性,为感染性角膜炎治疗提供了一种有前景的材料学策略。

3影像与人工智能 (6篇)

临床研究 (3篇)

Nature biotechnology IF 44.5 2026-10-06 PMID: 42839051
Hypertensive disorders of pregnancy arise from early placental and systemic vascular dysfunction, yet current first-trimester screening remains imprecise, biologically opaque and logistically challenging. Here we present Visionary AI, an interpretable platform that integrates retinal imaging with graph-based vascular modeling to predict hypertensive disorders before clinical onset. Visionary AI converts retinal images into topological and geometric representations of microvascular structure, enabling risk prediction from biologically grounded vascular features rather than generic image embeddings or clinical variables. In a prospective development cohort of 1,267 pregnancies, Visionary AI achieved strong performance for preeclampsia across population-wide control settings (area under the curve (AUC) = 0.91, average precision (AP) = 0.81). A stability-optimized model transferred without retraining to an independent external validation cohort, achieving AUC = 0.81 and AP = 0.68 and outperforming clinical and deep learning benchmarks. Recurrent features involving retinal vascular topology, geometry, network complexity and hierarchical organization position the maternal retina as a minimally invasive biosensor of systemic vascular health and Visionary AI as a biologically interpretable framework for pregnancy risk stratification.
中文摘要:妊娠期高血压疾病源于早期胎盘和全身血管功能障碍,然而当前孕早期筛查仍不精确、生物学机制不透明且实施上存在后勤挑战。在此,我们提出Visionary AI,一个可解释平台,将视网膜成像与基于图的血管建模相结合,以在临床发病前预测妊娠期高血压疾病。Visionary AI将视网膜图像转换为微血管结构的拓扑和几何表征,使风险预测能够基于有生物学依据的血管特征,而非通用图像嵌入或临床变量。在一个包含1,267例妊娠的前瞻性开发队列中,Visionary AI在全人群对照设置下对子痫前期取得良好性能(曲线下面积(AUC)=0.91,平均精度(AP)=0.81)。一个经稳定性优化的模型无需重新训练即迁移至一个独立外部验证队列,达到AUC=0.81和AP=0.68,并优于临床和深度学习基准。涉及视网膜血管拓扑、几何、网络复杂性和层级组织的重复特征,将母体视网膜定位为全身血管健康的微创生物传感器,并将Visionary AI定位为用于妊娠风险分层的、具有生物学可解释性的框架。
Ageing research reviews IF 15.5 2026-10 PMID: 42521027
Alzheimer's disease (AD) is characterized by progressive neurodegeneration and synaptic dysfunction that begins decades before clinical symptoms emerge. While AD research has traditionally focused on the brain, increasing evidence suggests that the retina undergoes pathological remodeling that shares features with cerebral changes. Advances in retinal imaging, including optical coherence tomography (OCT), OCT angiography, and hyperspectral approaches, have identified structural, vascular, and functional abnormalities in individuals with mild cognitive impairment (MCI) and early-stage AD. This supports the potential utility of the retina as a non-invasive biomarker for detecting neurodegenerative processes. Furthermore, postmortem studies have demonstrated accumulation of amyloid-β and phosphorylated tau, increased vulnerability of retinal ganglion cells (RGC), synaptic alterations in the inner plexiform layer (IPL), and significant activation of glial cells and complement-mediated inflammatory pathways. Melanopsin RGCs appear to be selectively affected, suggesting a mechanistic link between retinal pathology and the circadian or sleep disturbances commonly observed in AD. This review synthesizes human clinical data from imaging, histopathological, and proteomic studies supporting retinal involvement in AD, with emphasis on convergent mechanisms, including mitochondrial dysfunction, oxidative stress, microglial activation, and synaptic degeneration. Key limitations and sources of variation in current retinal biomarker studies, including cohort heterogeneity, comorbid ocular disease, and methodological variability, are discussed, and future directions are outlined to strengthen retinal diagnostics and therapeutic monitoring of visual system dysfunction in AD.
中文摘要:阿尔茨海默病(AD)以进行性神经退行性变和突触功能障碍为特征,这些改变在临床症状出现前数十年即已开始。尽管AD研究传统上聚焦于大脑,但越来越多证据提示视网膜发生与脑内改变具有共同特征的病理性重塑。视网膜成像的进展,包括OCT、OCT血管成像和高光谱方法,已在轻度认知障碍(MCI)和早期AD个体中识别出结构、血管和功能异常。这支持视网膜作为检测神经退行性过程的非侵入性生物标志物的潜在用途。此外,尸检研究已证实淀粉样蛋白β和磷酸化tau积累、视网膜神经节细胞(RGC)易感性增加、内丛状层(IPL)突触改变,以及胶质细胞和补体介导炎症通路的显著激活。黑视素RGCs似乎受到选择性影响,提示视网膜病理与AD中常见的昼夜节律或睡眠障碍之间存在机制联系。本综述综合了来自影像学、组织病理学和蛋白质组学研究的人类临床数据,这些数据支持视网膜参与AD,并强调汇聚机制,包括线粒体功能障碍、氧化应激、小胶质细胞激活和突触变性。讨论了当前视网膜生物标志物研究的主要局限性和变异来源,包括队列异质性、合并眼部疾病和方法学差异,并概述未来方向,以加强AD中视觉系统功能障碍的视网膜诊断和治疗监测。
Kidney international IF 21.8 2026-10 PMID: 42498059
Alport syndrome (AS) is a hereditary glomerulopathy often associated with ocular abnormalities, yet structural retinal biomarkers remain underutilized in nephrology. Here, we evaluated the Temporal Thinning Index Maximum (TTIMax), a subject-level optical coherence tomography (OCT) metric, as a potential diagnostic biomarker for inherited podocytopathies. We evaluated TTIMax derived from OCT in 93 genetically confirmed patients with AS and 136 controls (84 with chronic kidney disease and 52 healthy individuals). Genetic diagnosis served as the reference standard and TTIMax as the index test. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis with calculation of sensitivity and specificity. TTIMax stratified disease severity across genotypes (severe X-linked AS-Male/autosomal recessive AS: 11.8%; intermediate X-linked AS-Female/autosomal dominant AS: 7.3-8.1%; controls: 5.3-5.8%) and remained significantly associated with disease severity after adjustment for age, eGFR, and blood pressure. ROC analysis demonstrated excellent discrimination for severe AS (area under the curve (AUC) 0.98; 95% Confidence Interval 0.96-1.00) with an optimal threshold of 8.4% (sensitivity 93%, specificity 99%). TTIMax distinguished severe AS from primary immune-mediated focal segmental glomerulosclerosis (FSGS) (AUC 0.97; 0.94-1.00) and differentiated COL4A-related FSGS from primary FSGS (AUC 0.91; 0.77-1.00). Longitudinal follow-up (four-14 years) demonstrated stability of TTIMax despite changes in kidney function. TTIMax provides a widely accessible, non-invasive structural biomarker that complements genetic testing and may aid in diagnosing inherited podocytopathies and interpreting COL4 variants of uncertain significance.
中文摘要:阿尔波特综合征(AS)是一种遗传性肾小球病,常伴眼部异常,但结构性视网膜生物标志物在肾脏病学中仍未得到充分利用。在此,我们评估了颞侧变薄指数最大值(TTIMax),一种受试者水平的光学相干断层扫描(OCT)指标,作为遗传性足细胞病潜在诊断生物标志物。我们在93例经基因确诊的AS患者和136例对照者(84例慢性肾脏病患者和52例健康个体)中评估了由OCT得出的TTIMax。遗传诊断作为参考标准,TTIMax作为待评价试验。采用受试者工作特征(ROC)分析评估诊断性能,并计算敏感度和特异度。TTIMax可跨基因型对疾病严重程度进行分层(严重X连锁AS男性/常染色体隐性AS:11.8%;中间型X连锁AS女性/常染色体显性AS:7.3-8.1%;对照者:5.3-5.8%),且在调整年龄、eGFR和血压后仍与疾病严重程度显著相关。ROC分析显示其对严重AS具有极好的区分能力(曲线下面积(AUC)0.98;95%置信区间0.96-1.00),最佳阈值为8.4%(敏感度93%,特异度99%)。TTIMax可将严重AS与原发性免疫介导的局灶节段性肾小球硬化(FSGS)区分开(AUC 0.97;0.94-1.00),并可将COL4A相关FSGS与原发性FSGS区分开(AUC 0.91;0.77-1.00)。纵向随访(4-14年)显示,尽管肾功能发生变化,TTIMax仍保持稳定。TTIMax提供了一种广泛可及、无创的结构性生物标志物,可补充基因检测,并可能有助于诊断遗传性足细胞病以及解读意义未明的COL4变异。

基础研究 (3篇)

Science advances IF 13.9 2026-10-02 PMID: 42814805
The visual space is sampled by cortical field maps in which nearby neuronal populations encode nearby locations of images received from the retina. Whether retinotopic cortical organization already emerges in the neonatal or even prenatal human brain is currently unknown. To answer this question in vivo, we applied population connective field modeling to 871 resting-state functional magnetic resonance imaging datasets ranging from prenatal to young adult age. We found topographically organized eccentricity and polar angle connectivity maps in V2 and V3 of the visual cortex as early as the 21st week of gestation. These results highlight that human proto-retinotopic cortical maps develop in the second trimester of pregnancy, predating visual experience.
中文摘要:视觉空间由皮层场图采样,其中邻近的神经元群体编码来自视网膜图像的邻近位置。新生儿甚至胎儿人脑是否已经出现视网膜拓扑皮层组织,目前尚不清楚。为在体内回答这一问题,我们将群体连接场建模应用于871个静息态功能磁共振成像数据集,年龄范围从胎儿期到青年期。我们发现,早在妊娠第21周,视觉皮层V2和V3区就已存在拓扑组织的离心率和极角连接图。这些结果强调,人类原视网膜拓扑皮层图在妊娠中期发育,早于视觉经验。
JAMA ophthalmology IF 10.5 2026-10-01 PMID: 42821292
Altmetric Attention Scores (AAS) measure attention to scholarly articles through social media, news coverage, or policy citations. How AAS aligns with impact factors for ophthalmic peer-reviewed medical literature remains unclear. To assess correlations between AAS and citation metrics at the article and journal levels. This cross-sectional study included all citable items published between 2022 and 2023 in a subset of ophthalmology journals indexed in the 2024 Journal Citation Reports. The top 500 articles ranked by AAS were selected as a high-attention publication subset for detailed analysis. The primary outcome was Spearman rank correlations between AAS rankings and normalized citation rankings (calculated as total citations divided by months elapsed since publication) at the individual article level and between an entire journal's AAS rankings and Journal Impact Factor (JIF) rankings. This study included 24 059 citable items in 99 journals. Among the top 500 high-attention articles, correlation between individual article-level AAS rankings and citation rankings was 0.08 (95% CI, -0.01 to 0.16; P = .08). At the journal level, correlation was 0.57 (95% CI, 0.41-0.69; P < .001). Correlations for predominantly clinical research-oriented journals compared with predominantly nonclinically or mixed research-oriented journals were 0.64 (95% CI, 0.46-0.79) vs 0.43 (95% CI, 0.09-0.69) (difference = 0.21; 95% CI, -0.09 to 0.60; P = .24). Multivariable analysis showed that AAS rankings were independent of document type (review vs original article: β = -10.6; 95% CI, -47.8 to 26.6; P = .58) or publication date (per month elapsed: β = 0.7; 95% CI, -1.1 to 2.5; P = .45). In this cross-sectional study of high-attention ophthalmology publications, individual article-level AAS rank was not associated with citation rank, whereas journal-level Altmetric rank was moderately associated with JIF rank and greater for clinical research-oriented journals. These findings suggest that online attention and impact factor reflect partially overlapping but distinct dimensions of research dissemination and that both metrics are independent, important variables that may contribute to judging the value of peer-reviewed medical journals.
中文摘要:Altmetric关注度评分(AAS)通过社交媒体、新闻报道或政策引用衡量学术文章受到的关注。AAS与眼科同行评议医学文献影响因子之间的一致性仍不明确。旨在评估文章层面和期刊层面AAS与引用指标之间的相关性。这项横断面研究纳入了2024年《期刊引证报告》收录的部分眼科期刊中2022年至2023年发表的所有可引用条目。按AAS排名选取前500篇文章作为高关注度出版物子集进行详细分析。主要结局是文章层面AAS排名与标准化引用排名(按总引用次数除以自发表以来经过的月数计算)之间的Spearman等级相关性,以及整本期刊的AAS排名与期刊影响因子(JIF)排名之间的相关性。本研究纳入99种期刊中的24 059条可引用条目。在前500篇高关注度文章中,单篇文章层面AAS排名与引用排名之间的相关性为0.08(95%置信区间,-0.01至0.16;P=0.08)。在期刊层面,相关性为0.57(95%置信区间,0.41至0.69;P<0.001)。以临床研究为主的期刊与以非临床或混合研究为主的期刊相比,相关性分别为0.64(95%置信区间,0.46至0.79)和0.43(95%置信区间,0.09至0.69)(差异=0.21;95%置信区间,-0.09至0.60;P=0.24)。多变量分析显示,AAS排名与文献类型(综述与原创文章:β=-10.6;95%置信区间,-47.8至26.6;P=0.58)或发表日期(每经过一个月:β=0.7;95%置信区间,-1.1至2.5;P=0.45)无关。在这项针对高关注度眼科出版物的横断面研究中,单篇文章层面的AAS排名与引用排名无关,而期刊层面的Altmetric排名与JIF排名呈中度相关,且在以临床研究为主的期刊中相关性更强。这些发现提示,在线关注度和影响因子反映了研究传播中部分重叠但不同的维度,且这两个指标是独立且重要的变量,可能有助于判断同行评议医学期刊的价值。
IEEE transactions on medical imaging IF 12.4 2026-10 PMID: 42441440
Polarization-sensitive optical coherence tomography (PS-OCT) extends OCT by analyzing the polarization states of backscattered light to quantify tissue birefringence. However, conventional implementations require polarization-diverse detection and are therefore incompatible with most commercial OCT systems. As a result, PS-OCT has largely remained restricted to specialized research groups, limiting its broader scientific and clinical use. Here, we present a modular PS-OCT framework that integrates with a standard spectral-domain OCT platform through a detachable rotating achromatic half-wave plate in the sample arm. This waveplate modulates both incident and reflected polarization states. Three or more repeated measurements at distinct waveplate orientations enable reconstruction of the sample's round-trip Jones matrix and the corresponding polarization properties. To mitigate random phase variations between repeated measurements, we introduce a phase optimization strategy. We validate the framework with imaging of birefringent phantoms and the human retina in vivo, demonstrating reliable reconstruction of retardance and optic axis orientation. In this study, we implemented a polarization-sensitive module on the SPECTRALIS platform with minimal hardware modification. The framework could be extended to other OCT systems with appropriate mechanical integration and access to acquisition data. By reducing the hardware complexity typically associated with conventional PS-OCT, this framework may facilitate broader adoption of PS-OCT imaging in both research and clinical settings.
中文摘要:偏振敏感光学相干断层扫描(PS-OCT)通过分析背向散射光的偏振态来扩展OCT,以量化组织双折射。然而,传统实现方案需要偏振分集探测,因此与大多数商用OCT系统不兼容。因此,PS-OCT在很大程度上仍局限于专门的研究团队,限制了其更广泛的科研与临床应用。在此,我们提出了一种模块化PS-OCT框架,该框架通过样本臂中可拆卸的旋转消色差半波片与标准谱域OCT平台集成。该波片可调制入射和反射偏振态。在不同波片取向下进行三次或更多次重复测量,可重建样本的往返琼斯矩阵及相应的偏振特性。为减轻重复测量之间的随机相位变化,我们引入了一种相位优化策略。我们通过对双折射体模和人眼视网膜的在体成像验证了该框架,证明能够可靠重建延迟量和光轴方向。在本研究中,我们在SPECTRALIS平台上以最小的硬件改动实现了偏振敏感模块。该框架可通过适当的机械集成和数据采集访问扩展到其他OCT系统。通过降低传统PS-OCT通常伴随的硬件复杂性,该框架可能促进PS-OCT成像在科研和临床环境中的更广泛采用。

4白内障与屈光手术 (4篇)

基础研究 (4篇)

Chemical Society reviews IF 48.3 2026-10-02 PMID: 42825376
Neuromorphic vision is reaching an important transition from proof-of-concept device demonstrations toward quantitative energy benchmarks and scalable hardware integration. Yet, a chemistry-centered understanding of what attojoule-scale neuromorphic vision requires from materials and interfaces remains underdeveloped. Two-terminal (2T) photoelectric synapses are particularly well positioned for this transition by integrating sensing, memory, and computation within compact device architectures, while their performance, stability, scalability, and sustainability are fundamentally governed by materials selection and interfacial chemistry. This review therefore examines 2T photoelectric synapses from a coupled materials-device-system perspective. Starting from biological synapses and the human visual pathway, key biological concepts are translated into measurable device metrics and learning rules, followed by a comparison of the structural and operational characteristics of 2T and three-terminal (3T) architectures. The principal physical mechanisms governing photoelectric synaptic plasticity are then systematically discussed. Building on this mechanistic framework, materials-by-design strategies are examined across oxides, organic semiconductors, halide perovskites, and two-dimensional materials, with particular attention to their roles in device performance, stability, and energy efficiency. Representative neuromorphic vision functions, ranging from retina-inspired preprocessing to image recognition, are further reviewed together with device- and system-level energy considerations. Finally, safe-and-sustainable-by-design (SSbD) principles are incorporated to connect materials development with long-term technological and environmental requirements. Overall, this review highlights how coordinated materials, device, and system design can guide the development of energy-efficient, scalable, stable, and sustainable 2T photoelectric synapses for next-generation neuromorphic vision.
中文摘要:神经形态视觉正在从概念验证器件演示向定量能量基准和可扩展硬件集成实现重要转变。然而,以化学为中心的理解——即阿焦耳级神经形态视觉对材料和界面提出了哪些要求——仍不成熟。两端(2T)光电突触通过将传感、存储和计算集成在紧凑的器件架构中,特别适合这一转变,而其性能、稳定性、可扩展性和可持续性从根本上由材料选择和界面化学决定。因此,本综述从材料—器件—系统耦合视角审视2T光电突触。首先从生物突触和人视觉通路出发,将关键生物学概念转化为可测量的器件指标和学习规则,随后比较2T与三端(3T)架构的结构和工作特性。然后系统讨论主导光电突触可塑性的主要物理机制。在此机制框架基础上,考察氧化物、有机半导体、卤化物钙钛矿和二维材料中的材料按需设计策略,特别关注它们在器件性能、稳定性和能效中的作用。进一步综述具有代表性的神经形态视觉功能,从视网膜启发预处理到图像识别,并结合器件和系统层面的能量考量。最后,纳入安全与可持续设计(SSbD)原则,将材料开发与长期技术和环境需求联系起来。总体而言,本综述强调材料、器件和系统的协同设计如何指导开发高能效、可扩展、稳定且可持续的2T光电突触,用于下一代神经形态视觉。
Nature ecology & evolution IF 17.1 2026-10 PMID: 42717229
Terrestrial carnivores have repeatedly evolved similar ecomorphologies, yet the relationship between dental morphology and diet remains inconsistently predictive and seemingly at odds with this observation. Here we examine the presence of carnivore adaptive zones and this form/function mismatch using a total-evidence phylogeny of living and extinct feliforms, modelling the evolution of body mass and dental toolkit (relative blade length of the lower carnassial). We identify three adaptive zones within feliforms: (1) an ancestral cataract of carnivory, comprising small-bodied, ecologically flexible taxa with largely stochastic dental evolution; (2) the broad ecology cursor, associated with restricted forelimb dexterity and increased reliance on cranial prey processing; and (3) the soft-flesh specialist, defined by strong selection for slicing-dominated dentitions in hypercarnivores. Extending beyond feliforms, we propose a fourth zone, the versatile omnivore, representing a distinct adaptive zone of dietary and morphological flexibility at large size. Across these regimes, dental morphology receives strong selection only in hypercarnivores, resulting in reliable predictions of diet. In contrast, taxa with broader diets show stochastic dental evolution, leading to the frequent misclassification observed in recent studies. This framework reconciles longstanding links between morphology and ecology with their inconsistencies, providing a predictive model for terrestrial carnivore evolution.
中文摘要:陆生食肉动物曾多次演化出相似的生态形态,但牙齿形态与食性之间的关系在预测上仍不一致,且似乎与这一观察相矛盾。在此,我们利用现生与灭绝猫型类的全证据系统发育,对体重和牙齿工具组合(下裂齿的相对刃长)的演化进行建模,以检验食肉动物适应带的存在以及这种形态与功能不匹配。我们在猫型类内识别出三个适应带:(1)食肉性的祖先瀑布,包含体型小、生态上灵活、牙齿演化在很大程度上随机的类群;(2)广生态位游走者,与受限的前肢灵活性及对颅骨猎物处理的更大依赖相关;(3)软肉专食者,其特征是在超食肉动物中对以切割为主的齿列存在强选择。将范围扩展到猫型类之外,我们提出第四个适应带,即多能杂食者,代表在大型体型下具有食性和形态灵活性的一个独特适应带。在这些演化体制中,牙齿形态仅在超食肉动物中受到强选择,从而能够可靠地预测食性。相反,食性更广的类群表现出随机的牙齿演化,导致近期研究中频繁出现的误分类。这一框架调和了形态与生态之间长期存在的联系及其不一致性,为陆生食肉动物的演化提供了一个预测模型。
Sleep medicine reviews IF 11.6 2026-10 PMID: 42235468
Biological effects of light go beyond vision and influence non-image forming (NIF) brain functions such as sleep, circadian regulation, mood and cognition. These effects are primarily driven by the third class of photoreceptors (called ipRGCs), which are maximally sensitive to blue wavelength light and confer a maximal effectiveness to shorter wavelength light on NIF functions. Despite the growing recognition of the importance of light's NIF effects, most research has focused on young, healthy adults, while the impact of light may change during the early development and aging of the brain. This narrative review describes how the NIF effects of light change across the lifespan from foetus development and childhood (when data is available) through adolescence, adulthood and into older age. We begin by discussing how age impacts ocular structure, particularly the changes in photoreceptors. Our main focus is on cognitive brain functions which we define as the brain activity sustaining cognition as well as performance as the output of this activity. We highlight that evidence remains fragmented and unevenly distributed, particularly over the pre-adult trajectory, and that quantification of the lifespan changes is mostly not available. We further consider pupil and melatonin responses to light and circadian entrainment to allow approaching quantitative differences between age groups. We conclude by proposing future directions to reach the quantitative estimates needed by researchers, clinicians, policymakers, and designers to reach light interventions geared to a specific age group.
中文摘要:光的生物效应超越视觉,影响非图像形成(NIF)脑功能,如睡眠、昼夜节律调节、情绪和认知。这些效应主要由第三类光感受器(称为ipRGCs)驱动,它们对蓝光波长最敏感,并使较短波长光对NIF功能具有最大有效性。尽管人们日益认识到光NIF效应的重要性,大多数研究集中于年轻健康成人,而光的影响可能在大脑早期发育和衰老过程中发生变化。这篇叙述性综述描述了光NIF效应如何在从胎儿发育和儿童期(在有数据时)到青春期、成年期和老年期的整个生命周期中变化。我们首先讨论年龄如何影响眼部结构,特别是光感受器的变化。我们的主要关注点是我们定义为支撑认知的大脑活动以及作为该活动输出的表现的认知脑功能。我们强调,证据仍然零散且分布不均,尤其是在成年之前的轨迹上,而且大多无法获得生命周期变化的定量估计。我们进一步考虑瞳孔和褪黑素对光的反应以及昼夜节律同步,以便接近不同年龄组之间的定量差异。最后,我们提出未来方向,以实现研究人员、临床医生、政策制定者和设计师所需的定量估计,从而开展针对特定年龄组的光干预。
Journal of advanced research IF 17.1 2026-10 PMID: 41611124
Nasolacrimal duct obstruction (NLDO) is a common ophthalmic condition characterized by epiphora and ocular discharge. Its etiology remains poorly understood, and treatment primarily relies on surgical intervention due to a lack of effective drugs. To characterize the single-cell transcriptional landscape of the nasolacrimal duct in patients with nasolacrimal duct obstruction (NLDO) and to elucidate the immunoregulatory mechanisms underlying the key fibrotic process driving disease progression. Nasolacrimal duct tissues were obtained from 4 menopausal female patients by endoscopic dacryocystorhinostomy (DCR). Samples were collected from both the obstruction and para-blocked sites (Self-control of disease progression processes). Single-cell RNA sequencing was performed on the samples, and the cell composition and cell-cell interactions were analyzed. Subsequently, body fluid and tissue samples were obtained from 13 patients for histological and in vitro functional assays. Ten major cell types were identified in 67,658 cells of the nasolacrimal duct. Intercellular communication analysis revealed the critical role of macrophage migration inhibitory factor (MIF) in the interaction between fibroblasts and immune cells. Histological analysis revealed significant inflammation and fibrosis in nasolacrimal duct obstruction. Mechanistically, CD4+ T cell-derived MIF activated fibroblasts, promoting their proliferation. Subsequently, these fibroblasts secreted pro-inflammatory cytokines and extracellular matrix, which further stimulated CD4+ T cells. This created a self-perpetuating feedback loop that exacerbated disease progression. Overall, targeting MIF to disrupt this cycle presents a novel therapeutic approach to delay the progression to complete obstruction. This study delineates the cellular transcriptomic profile of the nasolacrimal duct in NLDO patients and demonstrates that the MIF-centered immunoregulatory axis acts as a key driver of fibrotic obstruction, while plasma cells and CD8+ T cells also contribute to the immune landscape. These findings provide critical insights into the immunoregulatory mechanisms underlying NLDO and highlight MIF-related pathways as potential therapeutic targets for impeding disease progression.
中文摘要:鼻泪管阻塞(NLDO)是一种常见眼科疾病,以溢泪和眼部溢液为特征。其病因仍不清楚,由于缺乏有效药物,治疗主要依赖手术干预。为描绘鼻泪管阻塞(NLDO)患者鼻泪管的单细胞转录图谱,并阐明驱动疾病进展的关键纤维化过程背后的免疫调节机制,研究通过内镜下泪囊鼻腔吻合术(DCR)从4例绝经期女性患者获取鼻泪管组织。样本取自阻塞部位和旁阻塞部位(疾病进展过程的自身对照)。对样本进行单细胞RNA测序,并分析细胞组成和细胞间相互作用。随后,从13例患者获取体液和组织样本,用于组织学和体外功能实验。在鼻泪管的67,658个细胞中鉴定出10种主要细胞类型。细胞间通讯分析揭示巨噬细胞迁移抑制因子(MIF)在成纤维细胞与免疫细胞相互作用中的关键作用。组织学分析显示鼻泪管阻塞中存在显著炎症和纤维化。机制上,CD4+ T细胞来源的MIF激活成纤维细胞,促进其增殖。随后,这些成纤维细胞分泌促炎细胞因子和细胞外基质,进一步刺激CD4+ T细胞。这形成了一个自我延续的反馈环路,加剧疾病进展。总体而言,靶向MIF以打断该循环,为延缓进展为完全阻塞提供了一种新的治疗策略。本研究描绘了NLDO患者鼻泪管的细胞转录组图谱,并证明以MIF为中心的免疫调节轴是纤维化阻塞的关键驱动因素,同时浆细胞和CD8+ T细胞也参与了免疫景观。这些发现为NLDO的免疫调节机制提供了关键见解,并突出MIF相关通路作为阻止疾病进展的潜在治疗靶点。

5角膜与眼表疾病 (2篇)

基础研究 (2篇)

Ultrasonics sonochemistry IF 10.2 2026-10 PMID: 42790152
Epithelium-off corneal collagen cross-linking (CXL) slows keratoconus progression but disrupts the epithelial barrier, whereas epithelium-on CXL is constrained by limited stromal riboflavin loading and insufficient evidence that physical delivery enhancement improves CXL outcomes in vivo keratoconus-like ectasia. Here, we developed microbubble-assisted pulsed low-intensity focused ultrasound (pLIFU) to enhance riboflavin transport through cavitation and evaluated its therapeutic effect in a collagenase-induced rabbit keratoconus-like model. Passive cavitation detection and temperature monitoring identified a treatment condition of 1 Hz pulse repetition frequency, 20 % duty cycle, 1.43 MPa focal-zone peak negative pressure, and 200 μl SonoVue solution, with maximum temperature rise limited to 1.5 °C. Hydrophone measurements showed low posterior-segment acoustic action, with a retinal-position mechanical index of approximately 0.076. Confocal fluorescence imaging showed that pLIFU with microbubbles increased peak stromal riboflavin fluorescence by 9.27 ± 2.16-fold (p < 0.0001) and effective penetration depth by 4.09-fold (p < 0.001) relative to control. In vivo, pLIFU-microbubble-enhanced CXL produced greater corneal flattening and a larger shear-wave-speed response than the US group. One month after treatment, central corneal curvature decreased by 45.85 ± 6.32 % and shear-wave speed (cs) increased by 52.50 ± 12.89 % relative to pretreatment in the USMB group. Short-term histology and inflammatory cytokine assays showed no sustained inflammatory elevation or overt retinal laminar disruption within the observation window. These findings support the early feasibility of pLIFU cavitation-enhanced riboflavin delivery as a physical augmentation strategy for epithelium-on CXL in keratoconus-like ectasia, with favourable short-term ocular tissue tolerance for the assessed endpoints; they do not establish non-inferiority to epithelium-off CXL or long-term safety and durability.
中文摘要:去上皮角膜胶原交联(CXL)可延缓圆锥角膜进展,但会破坏上皮屏障;而保留上皮的CXL受限于基质核黄素负载不足,并且缺乏物理递送增强可在体内圆锥角膜样扩张中改善CXL结局的证据。在此,我们开发了微泡辅助脉冲低强度聚焦超声(pLIFU),通过空化作用增强核黄素转运,并在胶原酶诱导的兔圆锥角膜样模型中评估其治疗效果。被动空化检测和温度监测确定了治疗条件:脉冲重复频率1 Hz、占空比20%、焦区峰值负压1.43 MPa、SonoVue溶液200 μl,最大温升限制在1.5 °C。水听器测量显示后节声学作用较低,视网膜位置机械指数约为0.076。共聚焦荧光成像显示,与对照相比,pLIFU联合微泡使基质核黄素荧光峰值增加9.27 ± 2.16倍(p < 0.0001),有效穿透深度增加4.09倍(p < 0.001)。在体内,pLIFU-微泡增强CXL产生的角膜变平程度和剪切波速度反应均大于US组。治疗后一个月,USMB组中央角膜曲率较治疗前下降45.85 ± 6.32%,剪切波速度(cs)增加52.50 ± 12.89%。短期组织学和炎症细胞因子检测显示,在观察窗口内未出现持续性炎症升高或明显的视网膜层状结构破坏。这些发现支持pLIFU空化增强核黄素递送作为圆锥角膜样扩张保留上皮CXL物理增强策略的早期可行性,并且所评估终点显示出良好的短期眼组织耐受性;但它们并未确立其相对于去上皮CXL的非劣效性或长期安全性和持久性。
Trends in biotechnology IF 16.6 2026-10 PMID: 41856808
Corneal diseases remain a leading cause of blindness, and corneal transplantation is the primary treatment for severe cases. However, the persistent shortage of donor corneas significantly limits this approach. Artificial corneas with engineered biomaterials designed to mimic the structure and function of native corneal tissue offer a promising alternative, and significant progress has been made, including FDA approval and clinical trials. Among emerging technologies, 3D printing enables personalized customization of implants tailored to patient needs, anatomy, and pathology. This method also enables precise control over the biomaterial composition and integration of living cells within the implant, enhancing post-transplantation regeneration. In this review, we examine the advancements in 3D-printed, proregenerative artificial corneas, focusing on innovative biofabrication and the challenges that remain in ensuring implant quality.
中文摘要:角膜疾病仍是导致失明的主要原因之一,而角膜移植是重症病例的主要治疗手段。然而,供体角膜持续短缺显著限制了这一方法。利用工程化生物材料设计、以模拟天然角膜组织结构和功能的人工角膜提供了一种有前景的替代方案,并且已取得显著进展,包括FDA批准和临床试验。在新兴技术中,3D打印能够实现根据患者需求、解剖结构和病理特征定制的植入物个性化定制。该方法还能精确控制生物材料组成,并在植入物中整合活细胞,从而增强移植后的再生。在这篇综述中,我们考察了3D打印、促再生人工角膜的进展,重点关注创新性生物制造以及确保植入物质量方面仍然存在的挑战。

6小儿眼科与斜视 (2篇)

临床研究 (1篇)

EClinicalMedicine IF 12.8 2026-10 PMID: 42775005
Small molecule inhibitors (SMIs) have become the cornerstone of treatment for patients with oncogene-driven non-small cell lung cancer (NSCLC), substantially improving clinical outcomes. Over the past decade, numerous agents targeting distinct oncogenic drives have been developed, each exhibiting unique pharmacokinetic and pharmacodynamic profiles that complicate clinical prescribing. This review highlights principal drug-interactions affecting SMI exposure, including concomitant food intake, gastric acid suppressants, modulators of cytochrome P450 (CYP) enzymes and drug transporters. Awareness of these factors may help prevent early treatment failure or severe adverse events due to under- or overexposure. Finally, the most prevalent and clinically relevant toxicities are discussed, including corrected QT interval (QTc) prolongation, pneumonitis, mucositis, weight gain, pyrexia, and ocular-, hepatic-, and neuro-toxicity. In line with recommendations from the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), this review which is based on extensive search of the scientific literature provides evidence-based practical guidance for prescribing SMIs in clinical practice.
中文摘要:小分子抑制剂(SMIs)已成为驱动基因阳性非小细胞肺癌(NSCLC)患者治疗的基石,显著改善了临床结局。过去十年中,针对不同致癌驱动因素的众多药物被开发出来,每种药物均具有独特的药代动力学和药效学特征,使临床处方变得复杂。本综述重点介绍影响SMI暴露的主要药物相互作用,包括同时摄入食物、胃酸抑制剂、细胞色素P450(CYP)酶调节剂和药物转运体。认识这些因素可能有助于避免因暴露不足或过度暴露而导致的早期治疗失败或严重不良事件。最后,本文讨论了最常见且具有临床相关性的毒性,包括校正QT间期(QTc)延长、肺炎、黏膜炎、体重增加、发热以及眼毒性、肝毒性和神经毒性。根据美国食品药品监督管理局(FDA)和欧洲药品管理局(EMA)的建议,本综述基于对科学文献的广泛检索,为临床实践中SMI处方提供循证实用指导。

基础研究 (1篇)

Ageing research reviews IF 15.5 2026-10 PMID: 42595187
Long-lived proteins provide a uniquely informative substrate for studying the molecular chemistry of human ageing, and the eye offers one of the most accessible and spatially resolved systems for examining this process. The lens remains the principal model: its central crystallins are synthesized during embryonic and early postnatal life and are retained throughout the lifespan, thereby preserving a cumulative record of irreversible chemical damage. We then extend this framework to other ocular compartments that contain long-lived or slowly turned-over proteins, including Bruch's membrane, the lens capsule and membrane proteome, the trabecular meshwork, and the corneal stroma, where cumulative chemical damage to structural proteins and extracellular matrices may likewise shape tissue ageing and disease susceptibility. With age, these proteins acquire extensive post-translational modifications, including deamidation, isoaspartate formation, racemization, truncation, oxidation, disulfide rearrangement, glycation, carbamylation, and photochemical adducts, which progressively reshape their conformational landscape. This review, we propose that the progressive, cumulative effect of these modifications constitutes a process defined as conformational drift: a chemically encoded displacement of protein ensembles away from their native conformational states toward heterogeneous, destabilized, poorly soluble, and aggregation-prone forms. For instance, in the lens, this process disrupts crystallin packing, depletes the chaperone reserve of α-crystallin, promotes phase separation and light scattering, and contributes to age-related stiffening of the lens nucleus. Finally, we critically evaluate current analytical strategies for mapping these molecular events and argue that the human eye offers an underused model for mechanistic geroscience beyond ophthalmology.
中文摘要:长寿命蛋白为研究人类衰老的分子化学提供了独特的信息性底物,而眼组织为研究这一过程提供了最易获取且具有空间分辨能力的系统之一。晶状体仍是主要模型:其中心区域的晶状体蛋白在胚胎期和出生后早期合成,并在整个生命周期中保留,从而保存了不可逆化学损伤的累积记录。随后,我们将这一框架扩展到其他含有长寿命蛋白或更新缓慢蛋白的眼部区域,包括布鲁赫膜、晶状体囊膜和膜蛋白组、小梁网以及角膜基质;在这些部位,结构蛋白和细胞外基质的累积性化学损伤同样可能塑造组织衰老和疾病易感性。随着年龄增长,这些蛋白会发生广泛的翻译后修饰,包括脱酰胺、异天冬氨酸形成、消旋化、截断、氧化、二硫键重排、糖化、氨甲酰化以及光化学加合物,这些修饰逐步重塑其构象景观。在本综述中,我们提出这些修饰的进行性、累积性效应构成一个称为构象漂移的过程:蛋白质集合体在化学编码驱动下偏离其天然构象状态,转向异质性、失稳、难溶且易聚集的形式。例如,在晶状体中,该过程破坏晶状体蛋白的堆积,耗竭α-晶状体蛋白的分子伴侣储备,促进相分离和光散射,并促成与年龄相关的晶状体核硬化。最后,我们批判性评估当前用于绘制这些分子事件的分析策略,并认为人眼为超越眼科学的机制性老年科学提供了一个尚未被充分利用的模型。

7基因治疗与再生医学 (1篇)

基础研究 (1篇)

Nature materials IF 38.0 2026-10 PMID: 42608547
Vision sensors are central to machine vision and intelligence. However, conventional planar devices rely on multielement optics and external processors to correct optical aberrations. This approach constrains miniaturization, reduces power efficiency and generally limits the field of view. Curved sensors can provide compact, aberration-corrected imaging, but their resolution has been below practicable levels. Here we present a bioinspired bionic eye system based on a hemispherical tandem artificial retina. This high curvature image sensor achieves a pixel density of 1,905 ppi with 367,500 total pixels, providing full-colour imaging across 300-800 nm and an aberration-corrected field of view exceeding 160°. Furthermore, the tandem design enables in-sensor, event-driven motion detection. Compared with frame-based imaging, this approach reduces the demand for bandwidth by over 99.95% and achieves a motion recognition accuracy of 98.6%. This work addresses the resolution bottleneck of hemispherical sensors and highlights their promise as compact, multifunctional vision applications.
中文摘要:视觉传感器是机器视觉和智能的核心。然而,传统平面器件依赖多元件光学系统和外部处理器来校正光学像差。这种方法限制了小型化,降低了能效,并且通常限制了视场。曲面传感器可以提供紧凑、像差校正的成像,但其分辨率一直低于实用水平。在此,我们提出一种基于半球形串联人工视网膜的仿生眼系统。这种高曲率图像传感器实现了1,905 ppi的像素密度,总像素数为367,500,在300-800 nm范围内提供全彩成像,并具有超过160°的像差校正视场。此外,串联设计实现了传感器内、事件驱动的运动检测。与基于帧的成像相比,这种方法将带宽需求降低超过99.95%,并达到98.6%的运动识别准确率。这项工作解决了半球形传感器的分辨率瓶颈,并突显了其作为紧凑、多功能视觉应用的潜力。

8葡萄膜炎与免疫 (1篇)

临床研究 (1篇)

Ophthalmology IF 10.9 2026-10 PMID: 42203133
To investigate the potential impact of ocular inflammation on development of antiadalimumab antibodies (AAAs) in patients with systemic autoimmune diseases treated with adalimumab. Retrospective case-control study. Patients who were treated with adalimumab for various autoimmune conditions for at least 6 months and were tested for adalimumab levels, AAA, or both from June 2005 through May 2024. The Stanford Research Repository database, a clinical data warehouse that aggregates electronic health records from Stanford Health Care, Stanford Children's Health, and affiliated clinics, was used to identify eligible participants. Demographic data, systemic diagnoses, ocular involvement, and prior and concurrent treatment also were collected. Subsequently, univariable and multivariable logistic regression analyses were conducted to identify factors associated with AAA development. The correlation of AAAs with ocular inflammation and the proportion of patients with positive AAA findings in the study cohort. Among 704 patients, 151 patients (21.5%) demonstrated AAAs. The group was predominantly female compared with the AAA-negative group (60.9% vs. 47.0%; adjusted odds ratio [aOR], 1.75; 95% confidence interval [CI], 1.07-2.85; P = 0.024). On multivariable analysis, ocular inflammation (aOR, 2.19; 95% CI, 1.19-4.02; P = 0.011), female sex (aOR, 1.75; 95% CI, 1.08-2.85; P = 0.024), and adalimumab interruption (aOR, 1.74; 95% CI, 1.03-2.94; P = 0.038) remained independent risk factors for AAA formation. Prior biologic therapy other than tumor necrosis factor (TNF)-α inhibitors was protective (aOR, 0.27; 95% CI, 0.08-0.98; P = 0.046), although prior TNF-α inhibitor exposure remained a risk factor (aOR, 2.11; 95% CI, 1.25-3.55; P = 0.005). Ocular inflammation in patients with autoimmune disorders is associated with an increased risk of AAA formation, prospective studies are needed to determine whether this reflects a mechanistic relationship and whether therapeutic drug monitoring in this subgroup improves clinical outcomes. Notably, more than one-fifth of patients receiving adalimumab in this cohort demonstrated AAAs. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
中文摘要:旨在探讨眼部炎症对接受阿达木单抗治疗的全身性自身免疫性疾病患者产生抗阿达木单抗抗体(AAAs)的潜在影响。回顾性病例对照研究。纳入2005年6月至2024年5月期间因各种自身免疫性疾病接受阿达木单抗治疗至少6个月,并检测过阿达木单抗水平、AAA或两者之一的患者。使用Stanford Research Repository数据库,这是一个临床数据仓库,整合了Stanford Health Care、Stanford Children's Health及附属诊所的电子健康记录,以识别合格参与者。还收集了人口学数据、全身诊断、眼部受累情况以及既往和同期治疗。随后进行单变量和多变量logistic回归分析,以确定与AAA产生相关的因素。研究队列中AAAs与眼部炎症的相关性以及AAA阳性患者的比例。704例患者中,151例(21.5%)检出AAAs。与AAA阴性组相比,该组以女性为主(60.9% vs. 47.0%;调整优势比[aOR] 1.75;95%置信区间[CI] 1.07-2.85;P = 0.024)。多变量分析中,眼部炎症(aOR 2.19;95% CI 1.19-4.02;P = 0.011)、女性(aOR 1.75;95% CI 1.08-2.85;P = 0.024)和阿达木单抗中断(aOR 1.74;95% CI 1.03-2.94;P = 0.038)仍是AAA形成的独立危险因素。既往使用非肿瘤坏死因子(TNF)-α抑制剂的生物制剂具有保护作用(aOR 0.27;95% CI 0.08-0.98;P = 0.046),尽管既往暴露于TNF-α抑制剂仍是危险因素(aOR 2.11;95% CI 1.25-3.55;P = 0.005)。自身免疫性疾病患者中的眼部炎症与AAA形成风险增加相关,需要前瞻性研究来确定这是否反映机制关系,以及该亚组中的治疗药物监测是否能改善临床结局。值得注意的是,该队列中超过五分之一的接受阿达木单抗治疗的患者检出AAAs。专有或商业披露可在本文末尾的脚注和披露部分找到。

9近视与屈光不正 (1篇)

临床研究 (1篇)

Ophthalmology IF 10.9 2026-10 PMID: 42019632
To evaluate real-world efficacy of diversified segmental defocus optimization (DSDO) lenses in controlling axial length (AL) growth compared with defocus incorporated multiple segments (DIMS) lenses and no optical correction in children and adolescents with or without myopia. Prospective, multicenter, clinical practice study. Individuals aged 6 to 16 were recruited from 8 Aier Eye Hospital Group centers in China and wore DSDO lenses, DIMS lenses, or no optical correction. Axial length was measured at baseline, 6 months, and 12 months after treatment initiation. Propensity score matching (PSM) was applied to balance baseline characteristics. Axial length changes were compared between DSDO and DIMS lenses in the myopia cohort and between DSDO lenses and untreated control participants in the nonmyopia cohort. Change in AL over the 6-month and 12-month follow-up periods. A total of 1541 participants were included (myopic group: 654 receiving DSDO lenses and 661 receiving DIMS lenses; nonmyopic group: 85 receiving DSDO lenses and 141 control participants). After PSM, baseline age, sex, spherical equivalent (SE), and AL were well balanced. In the myopic cohort, AL elongation was 0.07 ± 0.12 mm with DSDO lenses and 0.09 ± 0.10 mm with DIMS lenses at 6 months (P = 0.026) and 0.17 ± 0.18 mm versus 0.19 ± 0.16 mm, respectively, at 12 months (P = 0.019). In the nonmyopic cohort, AL growth was 0.18 ± 0.14 mm with DSDO lenses and 0.29 ± 0.14 mm in untreated control participants at 12 months (P = 0.01) and was greater in the hyperopic or emmetropic subgroup (0.00 < SE ≤ 1.50 diopters; P = 0.004). The most pronounced effect was observed within the first 6 months in the nonmyopic control participants. In the myopic cohort, subgroup analyses revealed greater efficacy in children 10 years of age or younger (P = 0.022) and in the low-myopia subgroup (P = 0.001). Age and intervention type independently predicted AL changes, whereas sex did not. Notably, baseline AL was significant determinant of subsequent AL changes in the myopia cohort. Compared with DIMS lenses, DSDO lenses provide greater control of axial elongation in specific myopic subgroups and effectively suppress physiologic axial growth in nonmyopic children and adolescents. The greatest advantage occurs during the first 6 months and among younger children with low baseline refractive error, highlighting the importance of early, individualized optical intervention for effective myopia prevention and control. The author(s) have no proprietary or commercial interest in any materials discussed in this article.
中文摘要:评估多样化分段离焦优化(DSDO)镜片与多区离焦(DIMS)镜片及未进行光学矫正相比,在伴或不伴近视的儿童和青少年中控制眼轴长度(AL)增长的真实世界疗效。这项前瞻性、多中心临床实践研究从中国8家爱尔眼科医院集团中心招募6至16岁个体,分别佩戴DSDO镜片、DIMS镜片或未进行光学矫正。在治疗开始基线、6个月和12个月时测量眼轴长度。采用倾向性评分匹配(PSM)平衡基线特征。在近视队列中比较DSDO镜片与DIMS镜片之间的眼轴长度变化,在非近视队列中比较DSDO镜片与未治疗对照组参与者之间的眼轴长度变化。主要观察6个月和12个月随访期间AL的变化。共纳入1541名参与者(近视组:654名接受DSDO镜片,661名接受DIMS镜片;非近视组:85名接受DSDO镜片,141名对照参与者)。PSM后,基线年龄、性别、等效球镜度(SE)和AL均平衡良好。在近视队列中,6个月时DSDO镜片组AL延长0.07±0.12 mm,DIMS镜片组为0.09±0.10 mm(P=0.026),12个月时分别为0.17±0.18 mm与0.19±0.16 mm(P=0.019)。在非近视队列中,12个月时DSDO镜片组AL增长0.18±0.14 mm,未治疗对照组为0.29±0.14 mm(P=0.01),并且在远视或正视亚组(0.00